41 results on '"Kang GW"'
Search Results
2. Prospects for observing and localizing gravitational-wave transients with Advanced LIGO, Advanced Virgo and KAGRA
- Author
-
Abbott, B. P., Abbott, R., Abbott, T. D., Abraham, S., Acernese, F., Ackley, K., Adams, C., Adya, V. B., Affeldt, C., Agathos, M., Agatsuma, K., Aggarwal, N., Aguiar, O. D., Aiello, L., Ain, A., Ajith, P., Akutsu, T., Allen, G., Allocca, A., Aloy, M. A., Altin, P. A., Amato, A., Ananyeva, A., Anderson, S. B., Anderson, W. G., Ando, M., Angelova, S. V., Antier, S., Appert, S., Arai, K., Arai, Koya, Arai, Y., Araki, S., Araya, A., Araya, M. C., Areeda, J. S., Arene, M., Aritomi, N., Arnaud, N., Arun, K. G., Ascenzi, S., Ashton, G., Aso, Y., Aston, S. M., Astone, P., Aubin, F., Aufmuth, P., AultONeal, K., Austin, C., Avendano, V., Avila-Alvarez, A., Babak, S., Bacon, P., Badaracco, F., Bader, M. K. M., Bae, S. W., Bae, Y. B., Baiotti, L., Bajpai, R., Baker, P. T., Baldaccini, F., Ballardin, G., Ballmer, S. W., Banagiri, S., Barayoga, J. C., Barclay, S. E., Barish, B. C., Barker, D., Barkett, K., Barnum, S., Barone, F., Barr, B., Barsotti, L., Barsuglia, M., Barta, D., Bartlett, J., Barton, M. A., Bartos, I., Bassiri, R., Basti, A., Bawaj, M., Bayley, J. C., Bazzan, M., Becsy, B., Bejger, M., Belahcene, I., Bell, A. S., Beniwal, D., Berger, B. K., Bergmann, G., Bernuzzi, S., Bero, J. J., Berry, C. P. L., Bersanetti, D., Bertolini, A., Betzwieser, J., Bhandare, R., Bidler, J., Bilenko, I. A., Bilgili, S. A., Billingsley, G., Birch, J., Birney, R., Birnholtz, O., Biscans, S., Biscoveanu, S., Bisht, A., Bitossi, M., Bizouard, M. A., Blackburn, J. K., Blair, C. D., Blair, D. G., Blair, R. M., Bloemen, S., Bode, N., Boer, M., Boetzel, Y., Bogaert, G., Bondu, F., Bonilla, E., Bonnand, R., Booker, P., Boom, B. A., Booth, C. D., Bork, R., Boschi, V., Bose, S., Bossie, K., Bossilkov, V., Bosveld, J., Bouffanais, Y., Bozzi, A., Bradaschia, C., Brady, P. R., Bramley, A., Branchesi, M., Brau, J. E., Briant, T., Briggs, J. H., Brighenti, F., Brillet, A., Brinkmann, M., Brisson, V., Brockill, P., Brooks, A. F., Brown, D. A., Brown, D. D., Brunett, S., Buikema, A., Bulik, T., Bulten, H. J., Buonanno, A., Buskulic, D., Buy, C., Byer, R. L., Cabero, M., Cadonati, L., Cagnoli, G., Cahillane, C., Bustillo, J. Calderon, Callister, T. A., Calloni, E., Camp, J. B., Campbell, W. A., Canepa, M., Cannon, K., Cannon, K. C., Cao, H., Cao, J., Capocasa, E., Carbognani, F., Caride, S., Carney, M. F., Carullo, G., Diaz, J. Casanueva, Casentini, C., Caudill, S., Cavaglia, M., Cavalier, F., Cavalieri, R., Cella, G., Cerda-Duran, P., Cerretani, G., Cesarini, E., Chaibi, O., Chakravarti, K., Chamberlin, S. J., Chan, M., Chan, M. L., Chao, S., Charlton, P., Chase, E. A., Chassande-Mottin, E., Chatterjee, D., Chaturvedi, M., Chatziioannou, K., Cheeseboro, B. D., Chen, C. S., Chen, H. Y., Chen, K. H., Chen, X., Chen, Y., Chen, Y. R., Cheng, H. -P., Cheong, C. K., Chia, H. Y., Chincarini, A., Chiummo, A., Cho, G., Cho, H. S., Cho, M., Christensen, N., Chu, H. Y., Chu, Q., Chu, Y. K., Chua, S., Chung, K. W., Chung, S., Ciani, G., Ciobanu, A. A., Ciolfi, R., Cipriano, F., Cirone, A., Clara, F., Clark, J. A., Clearwater, P., Cleva, F., Cocchieri, C., Coccia, E., Cohadon, P. -F., Cohen, D., Colgan, R., Colleoni, M., Collette, C. G., Collins, C., Cominsky, L. R., Constancio, M., Jr., Conti, L., Cooper, S. J., Corban, P., Corbitt, T. R., Cordero-Carrion, I., Corley, K. R., Cornish, N., Corsi, A., Cortese, S., Costa, C. A., Cotesta, R., Coughlin, M. W., Coughlin, S. B., Coulon, J. -P., Countryman, S. T., Couvares, P., Covas, P. B., Cowan, E. E., Coward, D. M., Cowart, M. J., Coyne, D. C., Coyne, R., Creighton, J. D. E., Creighton, T. D., Cripe, J., Croquette, M., Crowder, S. G., Cullen, T. J., Cumming, A., Cunningham, L., Cuoco, E., Canton, T. Dal, Dálya, Gergely, Danilishin, S. L., D'Antonio, S., Danzmann, K., Dasgupta, A., Da Silva Costa, C. F., Datrier, L. E. H., Dattilo, V., Dave, I., Davier, M., Davis, D., Daw, E. J., DeBra, D., Deenadayalan, M., Degallaix, J., De Laurentis, M., Deleglise, S., Pozzo, W. Del, DeMarchi, L. M., Demos, N., Dent, T., De Pietri, R., Derby, J., De Rosa, R., De Rossi, C., DeSalvo, R., de Varona, O., Dhurandhar, S., Diaz, M. C., Dietrich, T., Fiore, L. Di, Giovanni, M. Di, Girolamo, T. Di, Lieto, A. Di, Ding, B., Pace, S. Di, Palma, I. Di, Renzo, F. Di, Dmitriev, A., Doctor, Z., Doi, K., Donovan, F., Dooley, K. L., Doravari, S., Dorrington, I., Downes, T. P., Drago, M., Driggers, J. C., Du, Z., Ducoin, J. -G., Dupej, P., Dwyer, S. E., Easter, P. J., Edo, T. B., Edwards, M. C., Effler, A., Eguchi, S., Ehrens, P., Eichholz, J., Eikenberry, S. S., Eisenmann, M., Eisenstein, R. A., Enomoto, Y., Essick, R. C., Estelles, H., Estevez, D., Etienne, Z. B., Etzel, T., Evans, M., Evans, T. M., Fafone, V., Fair, H., Fairhurst, S., Fan, X., Farinon, S., Farr, B., Farr, W. M., Fauchon-Jones, E. J., Favata, M., Fays, M., Fazio, M., Fee, C., Feicht, J., Fejer, M. M., Feng, F., Fernandez-Galiana, A., Ferrante, I., Ferreira, E. C., Ferreira, T. A., Ferrini, F., Fidecaro, F., Fiori, I., Fiorucci, D., Fishbach, M., Fisher, R. P., Fishner, J. M., Fitz-Axen, M., Flaminio, R., Fletcher, M., Flynn, E., Fong, H., Font, J. A., Forsyth, P. W. F., Fournier, J. -D., Frasca, S., Frasconi, F., Frei, Z., Freise, A., Frey, R., Frey, V., Fritschel, P., Frolov, V. V., Fujii, Y., Fukunaga, M., Fukushima, M., Fulda, P., Fyffe, M., Gabbard, H. A., Gadre, B. U., Gaebel, S. M., Gair, J. R., Gammaitoni, L., Ganija, M. R., Gaonkar, S. G., Garcia, A., Garcia-Quiros, C., Garufi, F., Gateley, B., Gaudio, S., Gaur, G., Gayathri, V., Ge, G. G., Gemme, G., Genin, E., Gennai, A., George, D., George, J., Gergely, L., Germain, V., Ghonge, S., Ghosh, Abhirup, Ghosh, Archisman, Ghosh, S., Giacomazzo, B., Giaime, J. A., Giardina, K. D., Giazotto, A., Gill, K., Giordano, G., Glover, L., Godwin, P., Goetz, E., Goetz, R., Goncharov, B., Gonzalez, G., Castro, J. M. Gonzalez, Gopakumar, A., Gorodetsky, M. L., Gossan, S. E., Gosselin, M., Gouaty, R., Grado, A., Graef, C., Granata, M., Grant, A., Gras, S., Grassia, P., Gray, C., Gray, R., Greco, G., Green, A. C., Green, R., Gretarsson, E. M., Groot, P., Grote, H., Grunewald, S., Gruning, P., Guidi, G. M., Gulati, H. K., Guo, Y., Gupta, A., Gupta, M. K., Gustafson, E. K., Gustafson, R., Haegel, L., Hagiwara, A., Haino, S., Halim, O., Hall, B. R., Hall, E. D., Hamilton, E. Z., Hammond, G., Haney, M., Hanke, M. M., Hanks, J., Hanna, C., Hannam, M. D., Hannuksela, O. A., Hanson, J., Hardwick, T., Haris, K., Harms, J., Harry, G. M., Harry, I. W., Hasegawa, K., Haster, C. -J., Haughian, K., Hayakawa, H., Hayama, K., Hayes, F. J., Healy, J., Heidmann, A., Heintze, M. C., Heitmann, H., Hello, P., Hemming, G., Hendry, M., Heng, I. S., Hennig, J., Heptonstall, A. W., Heurs, M., Hild, S., Himemoto, Y., Hinderer, T., Hiranuma, Y., Hirata, N., Hirose, E., Hoak, D., Hochheim, S., Hofman, D., Holgado, A. M., Holland, N. A., Holt, K., Holz, D. E., Hong, Z., Hopkins, P., Horst, C., Hough, J., Howell, E. J., Hoy, C. G., Hreibi, A., Hsieh, B. H., Huang, G. Z., Huang, P. W., Huang, Y. J., Huerta, E. A., Huet, D., Hughey, B., Hulko, M., Husa, S., Huttner, S. H., Huynh-Dinh, T., Idzkowski, B., Iess, A., Ikenoue, B., Imam, S., Inayoshi, K., Ingram, C., Inoue, Y., Inta, R., Intini, G., Ioka, K., Irwin, B., Isa, H. N., Isac, J. -M., Isi, M., Itoh, Y., Iyer, B. R., Izumi, K., Jacqmin, T., Jadhav, S. J., Jani, K., Janthalur, N. N., Jaranowski, P., Jenkins, A. C., Jiang, J., Johnson, D. S., Jones, A. W., Jones, D. I., Jones, R., Jonker, R. J. G., Ju, L., Jung, K., Jung, P., Junker, J., Kajita, T., Kalaghatgi, C. V., Kalogera, V., Kamai, B., Kamiizumi, M., Kanda, N., Kandhasamy, S., Kang, G. W., Kanner, J. B., Kapadia, S. J., Karki, S., Karvinen, K. S., Kashyap, R., Kasprzack, M., Katsanevas, S., Katsavounidis, E., Katzman, W., Kaufer, S., Kawabe, K., Kawaguchi, K., Kawai, N., Kawasaki, T., Keerthana, N. V., Kefelian, F., Keitel, D., Kennedy, R., Key, J. S., Khalili, F. Y., Khan, H., Khan, I., Khan, S., Khan, Z., Khazanov, E. A., Khursheed, M., Kijbunchoo, N., Kim, Chunglee, Kim, C., Kim, J. C., Kim, J., Kim, K., Kim, W., Kim, W. S., Kim, Y. -M., Kimball, C., Kimura, N., King, E. J., King, P. J., Kinley-Hanlon, M., Kirchhoff, R., Kissel, J. S., Kita, N., Kitazawa, H., Kleybolte, L., Klika, J. H., Klimenko, S., Knowles, T. D., Knyazev, E., Koch, P., Koehlenbeck, S. M., Koekoek, G., Kojima, Y., Kokeyama, K., Koley, S., Komori, K., Kondrashov, V., Kong, A. K. H., Kontos, A., Koper, N., Korobko, M., Korth, W. Z., Kotake, K., Kowalska, I., Kozak, D. B., Kozakai, C., Kozu, R., Kringel, V., Krishnendu, N., Krolak, A., Kuehn, G., Kumar, A., Kumar, P., Kumar, Rahul, Kumar, R., Kumar, S., Kume, J., Kuo, C. M., Kuo, H. S., Kuo, L., Kuroyanagi, S., Kusayanagi, K., Kutynia, A., Kwak, K., Kwang, S., Lackey, B. D., Lai, K. H., Lam, T. L., Landry, M., Lane, B. B., Lang, R. N., Lange, J., Lantz, B., Lanza, R. K., Lartaux-Vollard, A., Lasky, P. D., Laxen, M., Lazzarini, A., Lazzaro, C., Leaci, P., Leavey, S., Lecoeuche, Y. K., Lee, C. H., Lee, H. K., Lee, H. M., Lee, H. W., Lee, J., Lee, K., Lee, R. K., Lehmann, J., Lenon, A., Leonardi, M., Leroy, N., Letendre, N., Levin, Y., Li, J., Li, K. J. L., Li, T. G. F., Li, X., Lin, C. Y., Lin, F., Lin, F. L., Lin, L. C. C., Linde, F., Linker, S. D., Littenberg, T. B., Liu, G. C., Liu, J., Liu, X., Lo, R. K. L., Lockerbie, N. A., London, L. T., Longo, A., Lorenzini, M., Loriette, V., Lormand, M., Losurdo, G., Lough, J. D., Lousto, C. O., Lovelace, G., Lower, M. E., Lueck, H., Lumaca, D., Lundgren, A. P., Luo, L. W., Lynch, R., Ma, Y., Macas, R., Macfoy, S., MacInnis, M., Macleod, D. M., Macquet, A., Magana-Sandoval, F., Zertuche, L. Magana, Magee, R. M., Majorana, E., Maksimovic, I., Malik, A., Man, N., Mandic, V., Mangano, V., Mansell, G. L., Manske, M., Mantovani, M., Marchesoni, F., Marchio, M., Marion, F., Marka, S., Marka, Z., Markakis, C., Markosyan, A. S., Markowitz, A., Maros, E., Marquina, A., Marsat, S., Martelli, F., Martin, I. W., Martin, R. M., Martynov, D. V., Mason, K., Massera, E., Masserot, A., Massinger, T. J., Masso-Reid, M., Mastrogiovanni, S., Matas, A., Matichard, F., Matone, L., Mavalvala, N., Mazumder, N., McCann, J. J., McCarthy, R., McClelland, D. E., McCormick, S., McCuller, L., McGuire, S. C., McIver, J., McManus, D. J., McRae, T., McWilliams, S. T., Meacher, D., Meadors, G. D., Mehmet, M., Mehta, A. K., Meidam, J., Melatos, A., Mendell, G., Mercer, R. A., Mereni, L., Merilh, E. L., Merzougui, M., Meshkov, S., Messenger, C., Messick, C., Metzdorff, R., Meyers, P. M., Miao, H., Michel, C., Michimura, Y., Middleton, H., Mikhailov, E. E., Milano, L., Miller, A. L., Miller, A., Millhouse, M., Mills, J. C., Milovich-Goff, M. C., Minazzoli, O., Minenkov, Y., Mio, N., Mishkin, A., Mishra, C., Mistry, T., Mitra, S., Mitrofanov, V. P., Mitselmakher, G., Mittleman, R., Miyakawa, O., Miyamoto, A., Miyazaki, Y., Miyo, K., Miyoki, S., Mo, G., Moffa, D., Mogushi, K., Mohapatra, S. R. P., Montani, M., Moore, C. J., Moraru, D., Moreno, G., Morisaki, S., Moriwaki, Y., Mours, B., Mow-Lowry, C. M., Mukherjee, Arunava, Mukherjee, D., Mukherjee, S., Mukund, N., Mullavey, A., Munch, J., Muniz, E. A., Muratore, M., Murray, P. G., Nagano, K., Nagano, S., Nagar, A., Nakamura, K., Nakano, H., Nakano, M., Nakashima, R., Nardecchia, I., Narikawa, T., Naticchioni, L., Nayak, R. K., Negishi, R., Neilson, J., Nelemans, G., Nelson, T. J. N., Nery, M., Neunzert, A., Ng, K. Y., Ng, S., Nguyen, P., Ni, W. T., Nichols, D., Nishizawa, A., Nissanke, S., Nocera, F., North, C., Nuttall, L. K., Obergaulinger, M., Oberling, J., O'Brien, B. D., Obuchi, Y., O'Dea, G. D., Ogaki, W., Ogin, G. H., Oh, J. J., Oh, S. H., Ohashi, M., Ohishi, N., Ohkawa, M., Ohme, F., Ohta, H., Okada, M. A., Okutomi, K., Oliver, M., Oohara, K., Ooi, C. P., Oppermann, P., Oram, Richard J., O'Reilly, B., Ormiston, R. G., Ortega, L. F., O'Shaughnessy, R., Oshino, S., Ossokine, S., Ottaway, D. J., Overmier, H., Owen, B. J., Pace, A. E., Pagano, G., Page, M. A., Pai, A., Pai, S. A., Palamos, J. R., Palashov, O., Palomba, C., Pal-Singh, A., Pan, Huang-Wei, Pan, K. C., Pang, B., Pang, H. F., Pang, P. T. H., Pankow, C., Pannarale, F., Pant, B. C., Paoletti, F., Paoli, A., Papa, M. A., Parida, A., Park, J., Parker, W., Pascucci, D., Pasqualetti, A., Passaquieti, R., Passuello, D., Patil, M., Patricelli, B., Pearlstone, B. L., Pedersen, C., Pedraza, M., Pedurand, R., Pele, A., Arellano, F. E. Pena, Penn, S., Perez, C. J., Perreca, A., Pfeiffer, H. P., Phelps, M., Phukon, K. S., Piccinni, O. J., Pichot, M., Piergiovanni, F., Pillant, G., Pinard, L., Pinto, I., Pirello, M., Pitkin, M., Poggiani, R., Pong, D. Y. T., Ponrathnam, S., Popolizio, P., Porter, E. K., Powell, J., Prajapati, A. K., Prasad, J., Prasai, K., Prasanna, R., Pratten, G., Prestegard, T., Privitera, S., Prodi, G. A., Prokhorov, L. G., Puncken, O., Punturo, M., Puppo, P., Puerrer, M., Qi, H., Quetschke, V., Quinonez, P. J., Quintero, E. A., Quitzow-James, R., Raab, F. J., Radkins, H., Radulescu, N., Raffai, P., Raja, S., Rajan, C., Rajbhandari, B., Rakhmanov, M., Ramirez, K. E., Ramos-Buades, A., Rana, Javed, Rao, K., Rapagnani, P., Raymond, V., Razzano, M., Read, J., Regimbau, T., Rei, L., Reid, S., Reitze, D. H., Ren, W., Ricci, F., Richardson, C. J., Richardson, J. W., Ricker, P. M., Riles, K., Rizzo, M., Robertson, N. A., Robie, R., Robinet, F., Rocchi, A., Rolland, L., Rollins, J. G., Roma, V. J., Romanelli, M., Romano, R., Romel, C. L., Romie, J. H., Rose, K., Rosinska, D., Rosofsky, S. G., Ross, M. P., Rowan, S., Ruediger, A., Ruggi, P., Rutins, G., Ryan, K., Sachdev, S., Sadecki, T., Sago, N., Saito, S., Saito, Y., Sakai, K., Sakai, Y., Sakamoto, H., Sakellariadou, M., Sakuno, Y., Salconi, L., Saleem, M., Samajdar, A., Sammut, L., Sanchez, E. J., Sanchez, L. E., Sanchis-Gual, N., Sandberg, V., Sanders, J. R., Santiago, K. A., Sarin, N., Sassolas, B., Sathyaprakash, B. S., Sato, S., Sato, T., Sauter, O., Savage, R. L., Sawada, T., Schale, P., Scheel, M., Scheuer, J., Schmidt, P., Schnabel, R., Schofield, R. M. S., Schoenbeck, A., Schreiber, E., Schulte, B. W., Schutz, B. F., Schwalbe, S. G., Scott, J., Scott, S. M., Seidel, E., Sekiguchi, T., Sekiguchi, Y., Sellers, D., Sengupta, A. S., Sennett, N., Sentenac, D., Sequino, V., Sergeev, A., Setyawati, Y., Shaddock, D. A., Shaffer, T., Shahriar, M. S., Shaner, M. B., Shao, L., Sharma, P., Shawhan, P., Shen, H., Shibagaki, S., Shimizu, R., Shimoda, T., Shimode, K., Shink, R., Shinkai, H., Shishido, T., Shoda, A., Shoemaker, D. H., Shoemaker, D. M., ShyamSundar, S., Siellez, K., Sieniawska, M., Sigg, D., Silva, A. D., Singer, L. P., Singh, N., Singhal, A., Sintes, A. M., Sitmukhambetov, S., Skliris, V., Slagmolen, B. J. J., Slaven-Blair, T. J., Smith, J. R., Smith, R. J. E., Somala, S., Somiya, K., Son, E. J., Sorazu, B., Sorrentino, F., Sotani, H., Souradeep, T., Sowell, E., Spencer, A. P., Srivastava, A. K., Srivastava, V., Staats, K., Stachie, C., Standke, M., Steer, D. A., Steinke, M., Steinlechner, J., Steinlechner, S., Steinmeyer, D., Stevenson, S. P., Stocks, D., Stone, R., Stops, D. J., Strain, K. A., Stratta, G., Strigin, S. E., Strunk, A., Sturani, R., Stuver, A. L., Sudhir, V., Sugimoto, R., Summerscales, T. Z., Sun, L., Sunil, S., Suresh, J., Sutton, P. J., Suzuki, Takamasa, Suzuki, Toshikazu, Swinkels, B. L., Szczepanczyk, M. J., Tacca, M., Tagoshi, H., Tait, S. C., Takahashi, H., Takahashi, R., Takamori, A., Takano, S., Takeda, H., Takeda, M., Talbot, C., Talukder, D., Tanaka, H., Tanaka, Kazuyuki, Tanaka, Kenta, Tanaka, Taiki, Tanaka, Takahiro, Tanioka, S., Tanner, D. B., Tapai, M., Martin, E. N. Tapia San, Taracchini, A., Tasson, J. D., Taylor, R., Telada, S., Thies, F., Thomas, M., Thomas, P., Thondapu, S. R., Thorne, K. A., Thrane, E., Tiwari, Shubhanshu, Tiwari, Srishti, Tiwari, V., Toland, K., Tomaru, T., Tomigami, Y., Tomura, T., Tonelli, M., Tornasi, Z., Torres-Forne, A., Torrie, C. I., Toyra, D., Travasso, F., Traylor, G., Tringali, M. C., Trovato, A., Trozzo, L., Trudeau, R., Tsang, K. W., Tsang, T. T. L., Tse, M., Tso, R., Tsubono, K., Tsuchida, S., Tsukada, L., Tsuna, D., Tsuzuki, T., Tuyenbayev, D., Uchikata, N., Uchiyama, T., Ueda, A., Uehara, T., Ueno, K., Ueshima, G., Ugolini, D., Unnikrishnan, C. S., Uraguchi, F., Urban, A. L., Ushiba, T., Usman, S. A., Vahlbruch, H., Vajente, G., Valdes, G., Bakel, N. van, Beuzekom, M. van, Brand, J. F. J. van den, Broeck, C. Van Den, Vander-Hyde, D. C., Schaaf, L. van der, Heijningen, J. V. van, Putten, M. H. P. M. van, Veggel, A. A. van, Vardaro, M., Varma, V., Vass, S., Vasuth, M., Vecchio, A., Vedovato, G., Veitch, J., Veitch, P. J., Venkateswara, K., Venugopalan, G., Verkindt, D., Vetrano, F., Vicere, A., Viets, A. D., Vine, D. J., Vinet, J. -Y., Vitale, S., Vivanco, Francisco Hernandez, Vo, T., Vocca, H., Vorvick, C., Vyatchanin, S. P., Wade, A. R., Wade, L. E., Wade, M., Walet, R., Walker, M., Wallace, L., Walsh, S., Wang, G., Wang, H., Wang, J., Wang, J. Z., Wang, W. H., Wang, Y. F., Ward, R. L., Warden, Z. A., Warner, J., Was, M., Watchi, J., Weaver, B., Wei, L. -W., Weinert, M., Weinstein, A. J., Weiss, R., Wellmann, F., Wen, L., Wessel, E. K., Wessels, P., Westhouse, J. W., Wette, K., Whelan, J. T., Whiting, B. F., Whittle, C., Wilken, D. M., Williams, D., Williamson, A. R., Willis, J. L., Willke, B., Wimmer, M. H., Winkler, W., Wipf, C. C., Wittel, H., Woan, G., Woehler, J., Wofford, J. K., Worden, J., Wright, J. L., Wu, C. M., Wu, D. S., Wu, H. C., Wu, S. R., Wysocki, D. M., Xiao, L., Xu, W. R., Yamada, T., Yamamoto, H., Yamamoto, Kazuhiro, Yamamoto, Kohei, Yamamoto, T., Yancey, C. C., Yang, L., Yap, M. J., Yazback, M., Yeeles, D. W., Yokogawa, K., Yokoyama, J., Yokozawa, T., Yoshioka, T., Yu, Hang, Yu, Haocun, Yuen, S. H. R., Yuzurihara, H., Yvert, M., Zadrozny, A. K., Zanolin, M., Zeidler, S., Zelenova, T., Zendri, J. -P., Zevin, M., Zhang, J., Zhang, L., Zhang, T., Zhao, C., Zhao, Y., Zhou, M., Zhou, Z., Zhu, X. J., Zhu, Z. H., Zimmerman, A. B., Zucker, M. E., Zweizig, J., KAGRA Collaboration, [ missing ], LIGO Scientific Collaboration and Virgo Collaboration, [ missing ], The KAGRA Collaboration, The LIGO Scientific Collaboration, The Virgo Collaboration, IoP (FNWI), Faculty of Science, Gravitation and Astroparticle Physics Amsterdam, Other Research IHEF (IoP, FNWI), Astroparticle Physics (IHEF, IoP, FNWI), Van Swinderen Institute for Particle Physics and G, Lincoln Laboratory, Massachusetts Institute of Technology. Department of Mechanical Engineering, Massachusetts Institute of Technology. Department of Physics, LIGO (Observatory : Massachusetts Institute of Technology), MIT Kavli Institute for Astrophysics and Space Research, Aggarwal, Nancy, Barsotti, Lisa, Biscans, Sebastien, Brown, N. M., Buikema, Aaron, Donovan, Frederick J, Eisenstein, Robert Alan, Essick, Reed Clasey, Fernandez Galiana, Alvaro-Miguel, Fritschel, Peter K, Gras, Slawomir, Isogai, Tomoki, Katsavounidis, Erotokritos, Kontos, Antonios, Lanza Jr, Robert K, Libson, Adam A., Lynch, Ryan Christopher, MacInnis, Myron E, Martynov, Denis, Mason, Kenneth R, Matichard, Fabrice, Mavalvala, Nergis, Miller, J., Mittleman, Richard K, Ray Pitambar Mohapatra, Satyanarayan, Oelker, Eric Glenn, Shoemaker, David H, Tse, Maggie, Vitale, Salvatore, Weiss, Rainer, Yam, William, Yu, Hang, Yu, Haocun, Zucker, Michael E, Evans, Matthew J, Science and Technology Facilities Council (UK), Max Planck Society, Australian Research Council, Istituto Nazionale di Fisica Nucleare, Centre National de la Recherche Scientifique (France), Department of Science and Technology (India), Govern de les Illes Balears, Generalitat Valenciana, National Science Centre (Poland), Swiss National Science Foundation, Russian Foundation for Basic Research, European Commission, Royal Society (UK), Scottish Funding Council, Hungarian Scientific Research Fund, National Research, Development and Innovation Office (Hungary), National Research Foundation of Korea, Ministério da Ciência e Tecnologia (Brasil), National Natural Science Foundation of China, Leverhulme Trust, Ministry of Science and Technology (Taiwan), Kavli Institute for Particle Astrophysics and Cosmology, Ministry of Education, Culture, Sports, Science and Technology (Japan), Japan Society for the Promotion of Science, University of Tokyo, Academia Sinica (Taiwan), Abbott, Bp, Abbott, R, Abbott, Td, Abraham, S, Acernese, F, Ackley, K, Adams, C, Adya, Vb, Affeldt, C, Agathos, M, Agatsuma, K, Aggarwal, N, Aguiar, Od, Aiello, L, Ain, A, Ajith, P, Akutsu, T, Allen, G, Allocca, A, Aloy, Ma, Altin, Pa, Amato, A, Ananyeva, A, Anderson, Sb, Anderson, Wg, Ando, M, Angelova, Sv, Antier, S, Appert, S, Arai, K, Arai, Y, Araki, S, Araya, A, Araya, Mc, Areeda, J, Arene, M, Aritomi, N, Arnaud, N, Arun, Kg, Ascenzi, S, Ashton, G, Aso, Y, Aston, Sm, Astone, P, Aubin, F, Aufmuth, P, Aultoneal, K, Austin, C, Avendano, V, Avila-Alvarez, A, Babak, S, Bacon, P, Badaracco, F, Bader, Mkm, Bae, Sw, Bae, Yb, Baiotti, L, Bajpai, R, Baker, Pt, Baldaccini, F, Ballardin, G, Ballmer, Sw, Banagiri, S, Barayoga, Jc, Barclay, Se, Barish, Bc, Barker, D, Barkett, K, Barnum, S, Barone, F, Barr, B, Barsotti, L, Barsuglia, M, Barta, D, Bartlett, J, Barton, Ma, Bartos, I, Bassiri, R, Basti, A, Bawaj, M, Bayley, Jc, Bazzan, M, Becsy, B, Bejger, M, Belahcene, I, Bell, A, Beniwal, D, Berger, Bk, Bergmann, G, Bernuzzi, S, Bero, Jj, Berry, Cpl, Bersanetti, D, Bertolini, A, Betzwieser, J, Bhandare, R, Bidler, J, Bilenko, Ia, Bilgili, Sa, Billingsley, G, Birch, J, Birney, R, Birnholtz, O, Biscans, S, Biscoveanu, S, Bisht, A, Bitossi, M, Bizouard, Ma, Blackburn, Jk, Blair, Cd, Blair, Dg, Blair, Rm, Bloemen, S, Bode, N, Boer, M, Boetzel, Y, Bogaert, G, Bondu, F, Bonilla, E, Bonnand, R, Booker, P, Boom, Ba, Booth, Cd, Bork, R, Boschi, V, Bose, S, Bossie, K, Bossilkov, V, Bosveld, J, Bouffanais, Y, Bozzi, A, Bradaschia, C, Brady, Pr, Bramley, A, Branchesi, M, Brau, Je, Briant, T, Briggs, Jh, Brighenti, F, Brillet, A, Brinkmann, M, Brisson, V, Brockill, P, Brooks, Af, Brown, Da, Brown, Dd, Brunett, S, Buikema, A, Bulik, T, Bulten, Hj, Buonanno, A, Buskulic, D, Buy, C, Byer, Rl, Cabero, M, Cadonati, L, Cagnoli, G, Cahillane, C, Bustillo, Jc, Callister, Ta, Calloni, E, Camp, Jb, Campbell, Wa, Canepa, M, Cannon, K, Cannon, Kc, Cao, H, Cao, J, Capocasa, E, Carbognani, F, Caride, S, Carney, Mf, Carullo, G, Diaz, Jc, Casentini, C, Caudill, S, Cavaglia, M, Cavalier, F, Cavalieri, R, Cella, G, Cerda-Duran, P, Cerretani, G, Cesarini, E, Chaibi, O, Chakravarti, K, Chamberlin, Sj, Chan, M, Chan, Ml, Chao, S, Charlton, P, Chase, Ea, Chassande-Mottin, E, Chatterjee, D, Chaturvedi, M, Chatziioannou, K, Cheeseboro, Bd, Chen, C, Chen, Hy, Chen, Kh, Chen, X, Chen, Y, Chen, Yr, Cheng, Hp, Cheong, Ck, Chia, Hy, Chincarini, A, Chiummo, A, Cho, G, Cho, H, Cho, M, Christensen, N, Chu, Hy, Chu, Q, Chu, Yk, Chua, S, Chung, Kw, Chung, S, Ciani, G, Ciobanu, Aa, Ciolfi, R, Cipriano, F, Cirone, A, Clara, F, Clark, Ja, Clearwater, P, Cleva, F, Cocchieri, C, Coccia, E, Cohadon, Pf, Cohen, D, Colgan, R, Colleoni, M, Collette, Cg, Collins, C, Cominsky, Lr, Constancio, M, Conti, L, Cooper, Sj, Corban, P, Corbitt, Tr, Cordero-Carrion, I, Corley, Kr, Cornish, N, Corsi, A, Cortese, S, Costa, Ca, Cotesta, R, Coughlin, Mw, Coughlin, Sb, Coulon, Jp, Countryman, St, Couvares, P, Covas, Pb, Cowan, Ee, Coward, Dm, Cowart, Mj, Coyne, Dc, Coyne, R, Creighton, Jde, Creighton, Td, Cripe, J, Croquette, M, Crowder, Sg, Cullen, Tj, Cumming, A, Cunningham, L, Cuoco, E, Canton, Td, Dalya, G, Danilishin, Sl, D'Antonio, S, Danzmann, K, Dasgupta, A, Costa, Cfd, Datrier, Leh, Dattilo, V, Dave, I, Davier, M, Davis, D, Daw, Ej, Debra, D, Deenadayalan, M, Degallaix, J, De Laurentis, M, Deleglise, S, Pozzo, Wd, Demarchi, Lm, Demos, N, Dent, T, De Pietri, R, Derby, J, De Rosa, R, De Rossi, C, Desalvo, R, de Varona, O, Dhurandhar, S, Diaz, Mc, Dietrich, T, Fiore, Ld, Giovanni, Md, Girolamo, Td, Lieto, Ad, Ding, B, Pace, Sd, Di Palma, I, Di Renzo, F, Dmitriev, A, Doctor, Z, Doi, K, Donovan, F, Dooley, Kl, Doravari, S, Dorrington, I, Downes, Tp, Drago, M, Driggers, Jc, Du, Z, Ducoin, Jg, Dupej, P, Dwyer, Se, Easter, Pj, Edo, Tb, Edwards, Mc, Effler, A, Eguchi, S, Ehrens, P, Eichholz, J, Eikenberry, S, Eisenmann, M, Eisenstein, Ra, Enomoto, Y, Essick, Rc, Estelles, H, Estevez, D, Etienne, Zb, Etzel, T, Evans, M, Evans, Tm, Fafone, V, Fair, H, Fairhurst, S, Fan, X, Farinon, S, Farr, B, Farr, Wm, Fauchon-Jones, Ej, Favata, M, Fays, M, Fazio, M, Fee, C, Feicht, J, Fejer, Mm, Feng, F, Fernandez-Galiana, A, Ferrante, I, Ferreira, Ec, Ferreira, Ta, Ferrini, F, Fidecaro, F, Fiori, I, Fiorucci, D, Fishbach, M, Fisher, Rp, Fishner, Jm, Fitz-Axen, M, Flaminio, R, Fletcher, M, Flynn, E, Fong, H, Font, Ja, Forsyth, Pwf, Fournier, Jd, Frasca, S, Frasconi, F, Frei, Z, Freise, A, Frey, R, Frey, V, Fritschel, P, Frolov, Vv, Fujii, Y, Fukunaga, M, Fukushima, M, Fulda, P, Fyffe, M, Gabbard, Ha, Gadre, Bu, Gaebel, Sm, Gair, Jr, Gammaitoni, L, Ganija, Mr, Gaonkar, Sg, Garcia, A, Garcia-Quiros, C, Garufi, F, Gateley, B, Gaudio, S, Gaur, G, Gayathri, V, Ge, Gg, Gemme, G, Genin, E, Gennai, A, George, D, George, J, Gergely, L, Germain, V, Ghonge, S, Ghosh, A, Ghosh, S, Giacomazzo, B, Giaime, Ja, Giardina, Kd, Giazotto, A, Gill, K, Giordano, G, Glover, L, Godwin, P, Goetz, E, Goetz, R, Goncharov, B, Gonzaalez, G, Castro, Jmg, Gopakumar, A, Gorodetsky, Ml, Gossan, Se, Gosselin, M, Gouaty, R, Grado, A, Graef, C, Granata, M, Grant, A, Gras, S, Grassia, P, Gray, C, Gray, R, Greco, G, Green, Ac, Green, R, Gretarsson, Em, Groot, P, Grote, H, Grunewald, S, Gruning, P, Guidi, Gm, Gulati, Hk, Guo, Y, Gupta, A, Gupta, Mk, Gustafson, Ek, Gustafson, R, Haegel, L, Hagiwara, A, Haino, S, Halim, O, Hall, Br, Hall, Ed, Hamilton, Ez, Hammond, G, Haney, M, Hanke, Mm, Hanks, J, Hanna, C, Hannam, Md, Hannuksela, Oa, Hanson, J, Hardwick, T, Haris, K, Harms, J, Harry, Gm, Harry, Iw, Hasegawa, K, Haster, Cj, Haughian, K, Hayakawa, H, Hayama, K, Hayes, Fj, Healy, J, Heidmann, A, Heintze, Mc, Heitmann, H, Hello, P, Hemming, G, Hendry, M, Heng, I, Hennig, J, Heptonstall, Aw, Heurs, M, Hild, S, Himemoto, Y, Hinderer, T, Hiranuma, Y, Hirata, N, Hirose, E, Hoak, D, Hochheim, S, Hofman, D, Holgado, Am, Holland, Na, Holt, K, Holz, De, Hong, Z, Hopkins, P, Horst, C, Hough, J, Howell, Ej, Hoy, Cg, Hreibi, A, Hsieh, Bh, Huang, Gz, Huang, Pw, Huang, Yj, Huerta, Ea, Huet, D, Hughey, B, Hulko, M, Husa, S, Huttner, Sh, Huynh-Dinh, T, Idzkowski, B, Iess, A, Ikenoue, B, Imam, S, Inayoshi, K, Ingram, C, Inoue, Y, Inta, R, Intini, G, Ioka, K, Irwin, B, Isa, Hn, Isac, Jm, Isi, M, Itoh, Y, Iyer, Br, Izumi, K, Jacqmin, T, Jadhav, Sj, Jani, K, Janthalur, Nn, Jaranowski, P, Jenkins, Ac, Jiang, J, Johnson, D, Jones, Aw, Jones, Di, Jones, R, Jonker, Rjg, Ju, L, Jung, K, Jung, P, Junker, J, Kajita, T, Kalaghatgi, Cv, Kalogera, V, Kamai, B, Kamiizumi, M, Kanda, N, Kandhasamy, S, Kang, Gw, Kanner, Jb, Kapadia, Sj, Karki, S, Karvinen, K, Kashyap, R, Kasprzack, M, Katsanevas, S, Katsavounidis, E, Katzman, W, Kaufer, S, Kawabe, K, Kawaguchi, K, Kawai, N, Kawasaki, T, Keerthana, Nv, Kefelian, F, Keitel, D, Kennedy, R, Key, J, Khalili, Fy, Khan, H, Khan, I, Khan, S, Khan, Z, Khazanov, Ea, Khursheed, M, Kijbunchoo, N, Kim, C, Kim, Jc, Kim, J, Kim, K, Kim, W, Kim, Ym, Kimball, C, Kimura, N, King, Ej, King, Pj, Kinley-Hanlon, M, Kirchhoff, R, Kissel, J, Kita, N, Kitazawa, H, Kleybolte, L, Klika, Jh, Klimenko, S, Knowles, Td, Knyazev, E, Koch, P, Koehlenbeck, Sm, Koekoek, G, Kojima, Y, Kokeyama, K, Koley, S, Komori, K, Kondrashov, V, Kong, Akh, Kontos, A, Koper, N, Korobko, M, Korth, Wz, Kotake, K, Kowalska, I, Kozak, Db, Kozakai, C, Kozu, R, Kringel, V, Krishnendu, N, Krolak, A, Kuehn, G, Kumar, A, Kumar, P, Kumar, R, Kumar, S, Kume, J, Kuo, Cm, Kuo, H, Kuo, L, Kuroyanagi, S, Kusayanagi, K, Kutynia, A, Kwak, K, Kwang, S, Lackey, Bd, Lai, Kh, Lam, Tl, Landry, M, Lane, Bb, Lang, Rn, Lange, J, Lantz, B, Lanza, Rk, Lartaux-Vollard, A, Lasky, Pd, Laxen, M, Lazzarini, A, Lazzaro, C, Leaci, P, Leavey, S, Lecoeuche, Yk, Lee, Ch, Lee, Hk, Lee, Hm, Lee, Hw, Lee, J, Lee, K, Lee, Rk, Lehmann, J, Lenon, A, Leonardi, M, Leroy, N, Letendre, N, Levin, Y, Li, J, Li, Kjl, Li, Tgf, Li, X, Lin, Cy, Lin, F, Lin, Fl, Lin, Lcc, Linde, F, Linker, Sd, Littenberg, Tb, Liu, Gc, Liu, J, Liu, X, Lo, Rkl, Lockerbie, Na, London, Lt, Longo, A, Lorenzini, M, Loriette, V, Lormand, M, Losurdo, G, Lough, Jd, Lousto, Co, Lovelace, G, Lower, Me, Luuck, H, Lumaca, D, Lundgren, Ap, Luo, Lw, Lynch, R, Ma, Y, Macas, R, Macfoy, S, Macinnis, M, Macleod, Dm, Macquet, A, Magana-Sandoval, F, Zertuche, Lm, Magee, Rm, Majorana, E, Maksimovic, I, Malik, A, Man, N, Mandic, V, Mangano, V, Mansell, Gl, Manske, M, Mantovani, M, Marchesoni, F, Marchio, M, Marion, F, Marka, S, Marka, Z, Markakis, C, Markosyan, A, Markowitz, A, Maros, E, Marquina, A, Marsat, S, Martelli, F, Martin, Iw, Martin, Rm, Martynov, Dv, Mason, K, Massera, E, Masserot, A, Massinger, Tj, Masso-Reid, M, Mastrogiovanni, S, Matas, A, Matichard, F, Matone, L, Mavalvala, N, Mazumder, N, Mccann, Jj, Mccarthy, R, Mcclelland, De, Mccormick, S, Mcculler, L, Mcguire, Sc, Mciver, J, Mcmanus, Dj, Mcrae, T, Mcwilliams, St, Meacher, D, Meadors, Gd, Mehmet, M, Mehta, Ak, Meidam, J, Melatos, A, Mendell, G, Mercer, Ra, Mereni, L, Merilh, El, Merzougui, M, Meshkov, S, Messenger, C, Messick, C, Metzdorff, R, Meyers, Pm, Miao, H, Michel, C, Michimura, Y, Middleton, H, Mikhailov, Ee, Milano, L, Miller, Al, Miller, A, Millhouse, M, Mills, Jc, Milovich-Goff, Mc, Minazzoli, O, Minenkov, Y, Mio, N, Mishkin, A, Mishra, C, Mistry, T, Mitra, S, Mitrofanov, Vp, Mitselmakher, G, Mittleman, R, Miyakawa, O, Miyamoto, A, Miyazaki, Y, Miyo, K, Miyoki, S, Mo, G, Moffa, D, Mogushi, K, Mohapatra, Srp, Montani, M, Moore, Cj, Moraru, D, Moreno, G, Morisaki, S, Moriwaki, Y, Mours, B, Mow-Lowry, Cm, Mukherjee, A, Mukherjee, D, Mukherjee, S, Mukund, N, Mullavey, A, Munch, J, Muniz, Ea, Muratore, M, Murray, Pg, Nagano, K, Nagano, S, Nagar, A, Nakamura, K, Nakano, H, Nakano, M, Nakashima, R, Nardecchia, I, Narikawa, T, Naticchioni, L, Nayak, Rk, Negishi, R, Neilson, J, Nelemans, G, Nelson, Tjn, Nery, M, Neunzert, A, Ng, Ky, Ng, S, Nguyen, P, Ni, Wt, Nichols, D, Nishizawa, A, Nissanke, S, Nocera, F, North, C, Nuttall, Lk, Obergaulinger, M, Oberling, J, O'Brien, Bd, Obuchi, Y, O'Dea, Gd, Ogaki, W, Ogin, Gh, Oh, Jj, Oh, Sh, Ohashi, M, Ohishi, N, Ohkawa, M, Ohme, F, Ohta, H, Okada, Ma, Okutomi, K, Oliver, M, Oohara, K, Ooi, Cp, Oppermann, P, Oram, Rj, O'Reilly, B, Ormiston, Rg, Ortega, Lf, O'Shaughnessy, R, Oshino, S, Ossokine, S, Ottaway, Dj, Overmier, H, Owen, Bj, Pace, Ae, Pagano, G, Page, Ma, Pai, A, Pai, Sa, Palamos, Jr, Palashov, O, Palomba, C, Pal-Singh, A, Pan, Hw, Pan, Kc, Pang, B, Pang, Hf, Pang, Pth, Pankow, C, Pannarale, F, Pant, Bc, Paoletti, F, Paoli, A, Papa, Ma, Parida, A, Park, J, Parker, W, Pascucci, D, Pasqualetti, A, Passaquieti, R, Passuello, D, Patil, M, Patricelli, B, Pearlstone, Bl, Pedersen, C, Pedraza, M, Pedurand, R, Pele, A, Arellano, Fep, Penn, S, Perez, Cj, Perreca, A, Pfeiffer, Hp, Phelps, M, Phukon, K, Piccinni, Oj, Pichot, M, Piergiovanni, F, Pillant, G, Pinard, L, Pinto, I, Pirello, M, Pitkin, M, Poggiani, R, Pong, Dyt, Ponrathnam, S, Popolizio, P, Porter, Ek, Powell, J, Prajapati, Ak, Prasad, J, Prasai, K, Prasanna, R, Pratten, G, Prestegard, T, Privitera, S, Prodi, Ga, Prokhorov, Lg, Puncken, O, Punturo, M, Puppo, P, Purer, M, Qi, H, Quetschke, V, Quinonez, Pj, Quintero, Ea, Quitzow-James, R, Raab, Fj, Radkins, H, Radulescu, N, Raffai, P, Raja, S, Rajan, C, Rajbhandari, B, Rakhmanov, M, Ramirez, Ke, Ramos-Buades, A, Rana, J, Rao, K, Rapagnani, P, Raymond, V, Razzano, M, Read, J, Regimbau, T, Rei, L, Reid, S, Reitze, Dh, Ren, W, Ricci, F, Richardson, Cj, Richardson, Jw, Ricker, Pm, Riles, K, Rizzo, M, Robertson, Na, Robie, R, Robinet, F, Rocchi, A, Rolland, L, Rollins, Jg, Roma, Vj, Romanelli, M, Romano, R, Romel, Cl, Romie, Jh, Rose, K, Rosinska, D, Rosofsky, Sg, Ross, Mp, Rowan, S, Ruiger, A, Ruggi, P, Rutins, G, Ryan, K, Sachdev, S, Sadecki, T, Sago, N, Saito, S, Saito, Y, Sakai, K, Sakai, Y, Sakamoto, H, Sakellariadou, M, Sakuno, Y, Salconi, L, Saleem, M, Samajdar, A, Sammut, L, Sanchez, Ej, Sanchez, Le, Sanchis-Gual, N, Sandberg, V, Sanders, Jr, Santiago, Ka, Sarin, N, Sassolas, B, Sathyaprakash, B, Sato, S, Sato, T, Sauter, O, Savage, Rl, Sawada, T, Schale, P, Scheel, M, Scheuer, J, Schmidt, P, Schnabel, R, Schofield, Rm, Schonbeck, A, Schreiber, E, Schulte, Bw, Schutz, Bf, Schwalbe, Sg, Scott, J, Scott, Sm, Seidel, E, Sekiguchi, T, Sekiguchi, Y, Sellers, D, Sengupta, A, Sennett, N, Sentenac, D, Sequino, V, Sergeev, A, Setyawati, Y, Shaddock, Da, Shaffer, T, Shahriar, M, Shaner, Mb, Shao, L, Sharma, P, Shawhan, P, Shen, H, Shibagaki, S, Shimizu, R, Shimoda, T, Shimode, K, Shink, R, Shinkai, H, Shishido, T, Shoda, A, Shoemaker, Dh, Shoemaker, Dm, Shyamsundar, S, Siellez, K, Sieniawska, M, Sigg, D, Silva, Ad, Singer, Lp, Singh, N, Singhal, A, Sintes, Am, Sitmukhambetov, S, Skliris, V, Slagmolen, Bjj, Slaven-Blair, Tj, Smith, Jr, Smith, Rje, Somala, S, Somiya, K, Son, Ej, Sorazu, B, Sorrentino, F, Sotani, H, Souradeep, T, Sowell, E, Spencer, Ap, Srivastava, Ak, Srivastava, V, Staats, K, Stachie, C, Standke, M, Steer, Da, Steinke, M, Steinlechner, J, Steinlechner, S, Steinmeyer, D, Stevenson, Sp, Stocks, D, Stone, R, Stops, Dj, Strain, Ka, Stratta, G, Strigin, Se, Strunk, A, Sturani, R, Stuver, Al, Sudhir, V, Sugimoto, R, Summerscales, Tz, Sun, L, Sunil, S, Suresh, J, Sutton, Pj, Suzuki, T, Swinkels, Bl, Szczepanczyk, Mj, Tacca, M, Tagoshi, H, Tait, Sc, Takahashi, H, Takahashi, R, Takamori, A, Takano, S, Takeda, H, Takeda, M, Talbot, C, Talukder, D, Tanaka, H, Tanaka, K, Tanaka, T, Tanioka, S, Tanner, Db, Tapai, M, San Martin, Ent, Taracchini, A, Tasson, Jd, Taylor, R, Telada, S, Thies, F, Thomas, M, Thomas, P, Thondapu, Sr, Thorne, Ka, Thrane, E, Tiwari, S, Tiwari, V, Toland, K, Tomaru, T, Tomigami, Y, Tomura, T, Tonelli, M, Tornasi, Z, Torres-Forne, A, Torrie, Ci, Toyra, D, Travasso, F, Traylor, G, Tringali, Mc, Trovato, A, Trozzo, L, Trudeau, R, Tsang, Kw, Tsang, Ttl, Tse, M, Tso, R, Tsubono, K, Tsuchida, S, Tsukada, L, Tsuna, D, Tsuzuki, T, Tuyenbayev, D, Uchikata, N, Uchiyama, T, Ueda, A, Uehara, T, Ueno, K, Ueshima, G, Ugolini, D, Unnikrishnan, C, Uraguchi, F, Urban, Al, Ushiba, T, Usman, Sa, Vahlbruch, H, Vajente, G, Valdes, G, van Bakel, N, van Beuzekom, M, van den Brand, Jfj, Van Den Broeck, C, Vander-Hyde, Dc, van den Schaaf, L, van Heijningen, Jv, van Putten, Mhpm, van Veggel, Aa, Vardaro, M, Varma, V, Vass, S, Vasuth, M, Vecchio, A, Vedovato, G, Veitch, J, Veitch, Pj, Venkateswara, K, Venugopalan, G, Verkindt, D, Vetrano, F, Vicere, A, Viets, Ad, Vine, Dj, Vinet, Jy, Vitale, S, Vivanco, Fh, Vo, T, Vocca, H, Vorvick, C, Vyatchanin, Sp, Wade, Ar, Wade, Le, Wade, M, Walet, R, Walker, M, Wallace, L, Walsh, S, Wang, G, Wang, H, Wang, J, Wang, Jz, Wang, Wh, Wang, Yf, Ward, Rl, Warden, Za, Warner, J, Was, M, Watchi, J, Weaver, B, Wei, Lw, Weinert, M, Weinstein, Aj, Weiss, R, Wellmann, F, Wen, L, Wessel, Ek, Wessels, P, Westhouse, Jw, Wette, K, Whelan, Jt, Whiting, Bf, Whittle, C, Wilken, Dm, Williams, D, Williamson, Ar, Willis, Jl, Willke, B, Wimmer, Mh, Winkler, W, Wipf, Cc, Wittel, H, Woan, G, Woehler, J, Wofford, Jk, Worden, J, Wright, Jl, Wu, Cm, Wu, D, Wu, Hc, Wu, Sr, Wysocki, Dm, Xiao, L, Xu, Wr, Yamada, T, Yamamoto, H, Yamamoto, K, Yamamoto, T, Yancey, Cc, Yang, L, Yap, Mj, Yazback, M, Yeeles, Dw, Yokogawa, K, Yokoyama, J, Yokozawa, T, Yoshioka, T, Yu, H, Yu, Hc, Yuen, Shr, Yuzurihara, H, Yvert, M, Zadrozny, Ak, Zanolin, M, Zeidler, S, Zelenova, T, Zendri, Jp, Zevin, M, Zhang, J, Zhang, L, Zhang, T, Zhao, C, Zhao, Y, Zhou, M, Zhou, Z, Zhu, Xj, Zhu, Zh, Zimmerman, Ab, Zucker, Me, Zweizig, J, Apollo - University of Cambridge Repository, Laboratoire des matériaux avancés (LMA), Centre National de la Recherche Scientifique (CNRS)-Institut National de Physique Nucléaire et de Physique des Particules du CNRS (IN2P3)-Université Claude Bernard Lyon 1 (UCBL), Université de Lyon-Université de Lyon, Laboratoire de l'Accélérateur Linéaire (LAL), Centre National de la Recherche Scientifique (CNRS)-Institut National de Physique Nucléaire et de Physique des Particules du CNRS (IN2P3)-Université Paris-Sud - Paris 11 (UP11), AstroParticule et Cosmologie (APC (UMR_7164)), Commissariat à l'énergie atomique et aux énergies alternatives (CEA)-Institut National de Physique Nucléaire et de Physique des Particules du CNRS (IN2P3)-Observatoire de Paris, Université Paris sciences et lettres (PSL)-Université Paris sciences et lettres (PSL)-Centre National de la Recherche Scientifique (CNRS)-Université de Paris (UP), Laboratoire d'Annecy de Physique des Particules (LAPP), Institut National de Physique Nucléaire et de Physique des Particules du CNRS (IN2P3)-Université Savoie Mont Blanc (USMB [Université de Savoie] [Université de Chambéry])-Centre National de la Recherche Scientifique (CNRS), Astrophysique Relativiste Théories Expériences Métrologie Instrumentation Signaux (ARTEMIS), Centre National de la Recherche Scientifique (CNRS)-Observatoire de la Côte d'Azur, Université Côte d'Azur (UCA)-COMUE Université Côte d'Azur (2015-2019) (COMUE UCA)-Université Côte d'Azur (UCA)-COMUE Université Côte d'Azur (2015-2019) (COMUE UCA)-Institut national des sciences de l'Univers (INSU - CNRS)-Université Nice Sophia Antipolis (... - 2019) (UNS), COMUE Université Côte d'Azur (2015-2019) (COMUE UCA), Institut des Fonctions Optiques pour les Technologies de l'informatiON (Institut FOTON), Université de Rennes 1 (UR1), Université de Rennes (UNIV-RENNES)-Université de Rennes (UNIV-RENNES)-Institut National des Sciences Appliquées - Rennes (INSA Rennes), Institut National des Sciences Appliquées (INSA)-Université de Rennes (UNIV-RENNES)-Institut National des Sciences Appliquées (INSA)-École Nationale Supérieure des Sciences Appliquées et de Technologie (ENSSAT)-Centre National de la Recherche Scientifique (CNRS)-IMT Atlantique Bretagne-Pays de la Loire (IMT Atlantique), Institut Mines-Télécom [Paris] (IMT)-Institut Mines-Télécom [Paris] (IMT), Laboratoire Kastler Brossel (LKB [Collège de France]), École normale supérieure - Paris (ENS Paris), Université Paris sciences et lettres (PSL)-Université Paris sciences et lettres (PSL)-Centre National de la Recherche Scientifique (CNRS)-Fédération de recherche du Département de physique de l'Ecole Normale Supérieure - ENS Paris (FRDPENS), Centre National de la Recherche Scientifique (CNRS)-École normale supérieure - Paris (ENS Paris), Université Paris sciences et lettres (PSL)-Université Paris sciences et lettres (PSL)-Centre National de la Recherche Scientifique (CNRS)-Sorbonne Université (SU)-Collège de France (CdF (institution)), Université Claude Bernard Lyon 1 (UCBL), Université de Lyon, Ecole Superieure de Physique et de Chimie Industrielles de la Ville de Paris (ESPCI Paris), Université Paris sciences et lettres (PSL), Institut des Hautes Etudes Scientifiques (IHES), IHES, KAGRA, LIGO Scientific, Virgo, Université de Lyon-Université de Lyon-Institut National de Physique Nucléaire et de Physique des Particules du CNRS (IN2P3)-Centre National de la Recherche Scientifique (CNRS), Université Paris-Sud - Paris 11 (UP11)-Institut National de Physique Nucléaire et de Physique des Particules du CNRS (IN2P3)-Centre National de la Recherche Scientifique (CNRS), Université Paris sciences et lettres (PSL)-Université Paris sciences et lettres (PSL)-Centre National de la Recherche Scientifique (CNRS)-Université Paris Cité (UPCité), Université Nice Sophia Antipolis (1965 - 2019) (UNS), COMUE Université Côte d'Azur (2015-2019) (COMUE UCA)-COMUE Université Côte d'Azur (2015-2019) (COMUE UCA)-Institut national des sciences de l'Univers (INSU - CNRS)-Observatoire de la Côte d'Azur, COMUE Université Côte d'Azur (2015-2019) (COMUE UCA)-Université Côte d'Azur (UCA)-Université Côte d'Azur (UCA)-Centre National de la Recherche Scientifique (CNRS), Université de Rennes (UR)-Institut National des Sciences Appliquées - Rennes (INSA Rennes), Institut National des Sciences Appliquées (INSA)-Institut National des Sciences Appliquées (INSA)-École Nationale Supérieure des Sciences Appliquées et de Technologie (ENSSAT)-Centre National de la Recherche Scientifique (CNRS), Fédération de recherche du Département de physique de l'Ecole Normale Supérieure - ENS Paris (FRDPENS), École normale supérieure - Paris (ENS-PSL), Université Paris sciences et lettres (PSL)-Université Paris sciences et lettres (PSL)-Centre National de la Recherche Scientifique (CNRS)-École normale supérieure - Paris (ENS-PSL), Université Paris sciences et lettres (PSL)-Université Paris sciences et lettres (PSL)-Centre National de la Recherche Scientifique (CNRS)-Collège de France (CdF (institution))-Sorbonne Université (SU)-Centre National de la Recherche Scientifique (CNRS), Institut des Hautes Études Scientifiques (IHES), Abbott, B, Abbott, T, Adya, V, Aguiar, O, Aloy, M, Altin, P, Anderson, S, Anderson, W, Angelova, S, Araya, M, Arun, K, Aston, S, Bader, M, Bae, S, Bae, Y, Baker, P, Ballmer, S, Barayoga, J, Barclay, S, Barish, B, Barton, M, Bayley, J, Berger, B, Bero, J, Berry, C, Bilenko, I, Bilgili, S, Bizouard, M, Blackburn, J, Blair, C, Blair, D, Blair, R, Boom, B, Booth, C, Brady, P, Brau, J, Briggs, J, Brooks, A, Brown, D, Bulten, H, Byer, R, Bustillo, J, Callister, T, Camp, J, Campbell, W, Carney, M, Diaz, J, Chamberlin, S, Chase, E, Cheeseboro, B, Chen, H, Chen, K, Cheng, H, Cheong, C, Chia, H, Chu, H, Chu, Y, Chung, K, Ciobanu, A, Clark, J, Cohadon, P, Collette, C, Cominsky, L, Cooper, S, Corbitt, T, Corley, K, Costa, C, Coughlin, M, Coughlin, S, Coulon, J, Countryman, S, Covas, P, Cowan, E, Coward, D, Cowart, M, Coyne, D, Creighton, J, Creighton, T, Crowder, S, Cullen, T, Canton, T, Danilishin, S, Da Silva Costa, C, Datrier, L, Daw, E, Pozzo, W, Demarchi, L, Diaz, M, Fiore, L, Giovanni, M, Girolamo, T, Lieto, A, Pace, S, Palma, I, Renzo, F, Dooley, K, Downes, T, Driggers, J, Ducoin, J, Dwyer, S, Easter, P, Edo, T, Edwards, M, Eisenstein, R, Essick, R, Etienne, Z, Evans, T, Farr, W, Fauchon-Jones, E, Fejer, M, Ferreira, E, Ferreira, T, Fisher, R, Fishner, J, Font, J, Forsyth, P, Fournier, J, Frolov, V, Gabbard, H, Gadre, B, Gaebel, S, Gair, J, Ganija, M, Gaonkar, S, Ge, G, Giaime, J, Giardina, K, Gonzalez, G, Castro, J, Gorodetsky, M, Gossan, S, Green, A, Gretarsson, E, Guidi, G, Gulati, H, Gupta, M, Gustafson, E, Hall, B, Hall, E, Hamilton, E, Hanke, M, Hannam, M, Hannuksela, O, Harry, G, Harry, I, Haster, C, Hayes, F, Heintze, M, Heptonstall, A, Holgado, A, Holland, N, Holz, D, Howell, E, Hoy, C, Hsieh, B, Huang, G, Huang, P, Huang, Y, Huerta, E, Huttner, S, Isa, H, Isac, J, Iyer, B, Jadhav, S, Janthalur, N, Jenkins, A, Jones, A, Jones, D, Jonker, R, Kalaghatgi, C, Kang, G, Kanner, J, Kapadia, S, Keerthana, N, Khalili, F, Khazanov, E, Kim, Y, King, E, King, P, Klika, J, Knowles, T, Koehlenbeck, S, Kong, A, Korth, W, Kozak, D, Kuo, C, Lackey, B, Lai, K, Lam, T, Lane, B, Lang, R, Lanza, R, Lasky, P, Lecoeuche, Y, Lee, C, Lee, H, Lee, R, Li, K, Li, T, Lin, C, Lin, L, Linker, S, Littenberg, T, Liu, G, Lo, R, Lockerbie, N, London, L, Lough, J, Lousto, C, Lower, M, Luck, H, Lundgren, A, Luo, L, Macleod, D, Zertuche, L, Magee, R, Mansell, G, Martin, I, Martin, R, Martynov, D, Massinger, T, Mccann, J, Mcclelland, D, Mcguire, S, Mcmanus, D, Mcwilliams, S, Meadors, G, Mehta, A, Mercer, R, Merilh, E, Meyers, P, Mikhailov, E, Mills, J, Milovich-Goff, M, Mitrofanov, V, Mohapatra, S, Moore, C, Mow-Lowry, C, Muniz, E, Murray, P, Nayak, R, Nelson, T, Ng, K, Ni, W, Nuttall, L, O'Brien, B, O'Dea, G, Ogin, G, Oh, J, Oh, S, Okada, M, Ooi, C, Oram, R, Ormiston, R, Ortega, L, Ottaway, D, Owen, B, Pace, A, Page, M, Pai, S, Palamos, J, Pan, H, Pan, K, Pang, H, Pang, P, Pant, B, Papa, M, Pearlstone, B, Arellano, F, Perez, C, Pfeiffer, H, Piccinni, O, Pong, D, Porter, E, Prajapati, A, Prodi, G, Prokhorov, L, Purrer, M, Quinonez, P, Quintero, E, Raab, F, Ramirez, K, Reitze, D, Richardson, C, Richardson, J, Ricker, P, Robertson, N, Rollins, J, Roma, V, Romel, C, Romie, J, Rosofsky, S, Ross, M, Rudiger, A, Sanchez, E, Sanchez, L, Sanders, J, Santiago, K, Savage, R, Schofield, R, Schulte, B, Schutz, B, Schwalbe, S, Scott, S, Shaddock, D, Shaner, M, Shoemaker, D, Silva, A, Singer, L, Sintes, A, Slagmolen, B, Slaven-Blair, T, Smith, J, Smith, R, Son, E, Spencer, A, Srivastava, A, Steer, D, Stevenson, S, Stops, D, Strain, K, Strigin, S, Stuver, A, Summerscales, T, Sutton, P, Swinkels, B, Szczepanczyk, M, Tait, S, Tanner, D, Martin, E, Tasson, J, Thondapu, S, Thorne, K, Torrie, C, Tringali, M, Tsang, K, Tsang, T, Urban, A, Usman, S, Bakel, N, Beuzekom, M, Brand, J, Broeck, C, Vander-Hyde, D, Schaaf, L, Heijningen, J, Putten, M, Veggel, A, Veitch, P, Viets, A, Vine, D, Vinet, J, Vivanco, F, Vyatchanin, S, Wade, A, Wade, L, Wang, W, Wang, Y, Ward, R, Warden, Z, Wei, L, Weinstein, A, Wessel, E, Westhouse, J, Whelan, J, Whiting, B, Wilken, D, Williamson, A, Willis, J, Wimmer, M, Wipf, C, Wofford, J, Wright, J, Wu, C, Wu, H, Wu, S, Wysocki, D, Xu, W, Yancey, C, Yap, M, Yeeles, D, Yuen, S, Zadrozny, A, Zendri, J, Zhu, X, Zhu, Z, Zimmerman, A, Zucker, M, Abbott, B. P., Abbott, R., Abbott, T. D., Abraham, S., Acernese, F., Ackley, K., Adams, C., Adya, V. B., Affeldt, C., Agathos, M., Agatsuma, K., Aggarwal, N., Aguiar, O. D., Aiello, L., Ain, A., Ajith, P., Akutsu, T., Allen, G., Allocca, A., Aloy, M. A., Altin, P. A., Amato, A., Ananyeva, A., Anderson, S. B., Anderson, W. G., Ando, M., Angelova, S. V., Antier, S., Appert, S., Arai, K., Arai, Y., Araki, S., Araya, A., Araya, M. C., Areeda, J. S., Arene, M., Aritomi, N., Arnaud, N., Arun, K. G., Ascenzi, S., Ashton, G., Aso, Y., Aston, S. M., Astone, P., Aubin, F., Aufmuth, P., Aultoneal, K., Austin, C., Avendano, V., Avila-Alvarez, A., Babak, S., Bacon, P., Badaracco, F., Bader, M. K. M., Bae, S. W., Bae, Y. B., Baiotti, L., Bajpai, R., Baker, P. T., Baldaccini, F., Ballardin, G., Ballmer, S. W., Banagiri, S., Barayoga, J. C., Barclay, S. E., Barish, B. C., Barker, D., Barkett, K., Barnum, S., Barone, F., Barr, B., Barsotti, L., Barsuglia, M., Barta, D., Bartlett, J., Barton, M. A., Bartos, I., Bassiri, R., Basti, A., Bawaj, M., Bayley, J. C., Bazzan, M., Becsy, B., Bejger, M., Belahcene, I., Bell, A. S., Beniwal, D., Berger, B. K., Bergmann, G., Bernuzzi, S., Bero, J. J., Berry, C. P. L., Bersanetti, D., Bertolini, A., Betzwieser, J., Bhandare, R., Bidler, J., Bilenko, I. A., Bilgili, S. A., Billingsley, G., Birch, J., Birney, R., Birnholtz, O., Biscans, S., Biscoveanu, S., Bisht, A., Bitossi, M., Bizouard, M. A., Blackburn, J. K., Blair, C. D., Blair, D. G., Blair, R. M., Bloemen, S., Bode, N., Boer, M., Boetzel, Y., Bogaert, G., Bondu, F., Bonilla, E., Bonnand, R., Booker, P., Boom, B. A., Booth, C. D., Bork, R., Boschi, V., Bose, S., Bossie, K., Bossilkov, V., Bosveld, J., Bouffanais, Y., Bozzi, A., Bradaschia, C., Brady, P. R., Bramley, A., Branchesi, M., Brau, J. E., Briant, T., Briggs, J. H., Brighenti, F., Brillet, A., Brinkmann, M., Brisson, V., Brockill, P., Brooks, A. F., Brown, D. A., Brown, D. D., Brunett, S., Buikema, A., Bulik, T., Bulten, H. J., Buonanno, A., Buskulic, D., Buy, C., Byer, R. L., Cabero, M., Cadonati, L., Cagnoli, G., Cahillane, C., Bustillo, J. C., Callister, T. A., Calloni, E., Camp, J. B., Campbell, W. A., Canepa, M., Cannon, K., Cannon, K. C., Cao, H., Cao, J., Capocasa, E., Carbognani, F., Caride, S., Carney, M. F., Carullo, G., Diaz, J. C., Casentini, C., Caudill, S., Cavaglia, M., Cavalier, F., Cavalieri, R., Cella, G., Cerda-Duran, P., Cerretani, G., Cesarini, E., Chaibi, O., Chakravarti, K., Chamberlin, S. J., Chan, M., Chan, M. L., Chao, S., Charlton, P., Chase, E. A., Chassande-Mottin, E., Chatterjee, D., Chaturvedi, M., Chatziioannou, K., Cheeseboro, B. D., Chen, C. S., Chen, H. Y., Chen, K. H., Chen, X., Chen, Y., Chen, Y. R., Cheng, H. -P., Cheong, C. K., Chia, H. Y., Chincarini, A., Chiummo, A., Cho, G., Cho, H. S., Cho, M., Christensen, N., Chu, H. Y., Chu, Q., Chu, Y. K., Chua, S., Chung, K. W., Chung, S., Ciani, G., Ciobanu, A. A., Ciolfi, R., Cipriano, F., Cirone, A., Clara, F., Clark, J. A., Clearwater, P., Cleva, F., Cocchieri, C., Coccia, E., Cohadon, P. -F., Cohen, D., Colgan, R., Colleoni, M., Collette, C. G., Collins, C., Cominsky, L. R., Constancio, M., Conti, L., Cooper, S. J., Corban, P., Corbitt, T. R., Cordero-Carrion, I., Corley, K. R., Cornish, N., Corsi, A., Cortese, S., Costa, C. A., Cotesta, R., Coughlin, M. W., Coughlin, S. B., Coulon, J. -P., Countryman, S. T., Couvares, P., Covas, P. B., Cowan, E. E., Coward, D. M., Cowart, M. J., Coyne, D. C., Coyne, R., Creighton, J. D. E., Creighton, T. D., Cripe, J., Croquette, M., Crowder, S. G., Cullen, T. J., Cumming, A., Cunningham, L., Cuoco, E., Canton, T. D., Dalya, G., Danilishin, S. L., D'Antonio, S., Danzmann, K., Dasgupta, A., Da Silva Costa, C. F., Datrier, L. E. H., Dattilo, V., Dave, I., Davier, M., Davis, D., Daw, E. J., Debra, D., Deenadayalan, M., Degallaix, J., De Laurentis, M., Deleglise, S., Pozzo, W. D., Demarchi, L. M., Demos, N., Dent, T., De Pietri, R., Derby, J., De Rosa, R., De Rossi, C., Desalvo, R., de Varona, O., Dhurandhar, S., Diaz, M. C., Dietrich, T., Fiore, L. D., Giovanni, M. D., Girolamo, T. D., Lieto, A. D., Ding, B., Pace, S. D., Palma, I. D., Renzo, F. D., Dmitriev, A., Doctor, Z., Doi, K., Donovan, F., Dooley, K. L., Doravari, S., Dorrington, I., Downes, T. P., Drago, M., Driggers, J. C., Du, Z., Ducoin, J. -G., Dupej, P., Dwyer, S. E., Easter, P. J., Edo, T. B., Edwards, M. C., Effler, A., Eguchi, S., Ehrens, P., Eichholz, J., Eikenberry, S. S., Eisenmann, M., Eisenstein, R. A., Enomoto, Y., Essick, R. C., Estelles, H., Estevez, D., Etienne, Z. B., Etzel, T., Evans, M., Evans, T. M., Fafone, V., Fair, H., Fairhurst, S., Fan, X., Farinon, S., Farr, B., Farr, W. M., Fauchon-Jones, E. J., Favata, M., Fays, M., Fazio, M., Fee, C., Feicht, J., Fejer, M. M., Feng, F., Fernandez-Galiana, A., Ferrante, I., Ferreira, E. C., Ferreira, T. A., Ferrini, F., Fidecaro, F., Fiori, I., Fiorucci, D., Fishbach, M., Fisher, R. P., Fishner, J. M., Fitz-Axen, M., Flaminio, R., Fletcher, M., Flynn, E., Fong, H., Font, J. A., Forsyth, P. W. F., Fournier, J. -D., Frasca, S., Frasconi, F., Frei, Z., Freise, A., Frey, R., Frey, V., Fritschel, P., Frolov, V. V., Fujii, Y., Fukunaga, M., Fukushima, M., Fulda, P., Fyffe, M., Gabbard, H. A., Gadre, B. U., Gaebel, S. M., Gair, J. R., Gammaitoni, L., Ganija, M. R., Gaonkar, S. G., Garcia, A., Garcia-Quiros, C., Garufi, F., Gateley, B., Gaudio, S., Gaur, G., Gayathri, V., Ge, G. G., Gemme, G., Genin, E., Gennai, A., George, D., George, J., Gergely, L., Germain, V., Ghonge, S., Ghosh, A., Ghosh, S., Giacomazzo, B., Giaime, J. A., Giardina, K. D., Giazotto, A., Gill, K., Giordano, G., Glover, L., Godwin, P., Goetz, E., Goetz, R., Goncharov, B., Gonzalez, G., Castro, J. M. G., Gopakumar, A., Gorodetsky, M. L., Gossan, S. E., Gosselin, M., Gouaty, R., Grado, A., Graef, C., Granata, M., Grant, A., Gras, S., Grassia, P., Gray, C., Gray, R., Greco, G., Green, A. C., Green, R., Gretarsson, E. M., Groot, P., Grote, H., Grunewald, S., Gruning, P., Guidi, G. M., Gulati, H. K., Guo, Y., Gupta, A., Gupta, M. K., Gustafson, E. K., Gustafson, R., Haegel, L., Hagiwara, A., Haino, S., Halim, O., Hall, B. R., Hall, E. D., Hamilton, E. Z., Hammond, G., Haney, M., Hanke, M. M., Hanks, J., Hanna, C., Hannam, M. D., Hannuksela, O. A., Hanson, J., Hardwick, T., Haris, K., Harms, J., Harry, G. M., Harry, I. W., Hasegawa, K., Haster, C. -J., Haughian, K., Hayakawa, H., Hayama, K., Hayes, F. J., Healy, J., Heidmann, A., Heintze, M. C., Heitmann, H., Hello, P., Hemming, G., Hendry, M., Heng, I. S., Hennig, J., Heptonstall, A. W., Heurs, M., Hild, S., Himemoto, Y., Hinderer, T., Hiranuma, Y., Hirata, N., Hirose, E., Hoak, D., Hochheim, S., Hofman, D., Holgado, A. M., Holland, N. A., Holt, K., Holz, D. E., Hong, Z., Hopkins, P., Horst, C., Hough, J., Howell, E. J., Hoy, C. G., Hreibi, A., Hsieh, B. H., Huang, G. Z., Huang, P. W., Huang, Y. J., Huerta, E. A., Huet, D., Hughey, B., Hulko, M., Husa, S., Huttner, S. H., Huynh-Dinh, T., Idzkowski, B., Iess, A., Ikenoue, B., Imam, S., Inayoshi, K., Ingram, C., Inoue, Y., Inta, R., Intini, G., Ioka, K., Irwin, B., Isa, H. N., Isac, J. -M., Isi, M., Itoh, Y., Iyer, B. R., Izumi, K., Jacqmin, T., Jadhav, S. J., Jani, K., Janthalur, N. N., Jaranowski, P., Jenkins, A. C., Jiang, J., Johnson, D. S., Jones, A. W., Jones, D. I., Jones, R., Jonker, R. J. G., Ju, L., Jung, K., Jung, P., Junker, J., Kajita, T., Kalaghatgi, C. V., Kalogera, V., Kamai, B., Kamiizumi, M., Kanda, N., Kandhasamy, S., Kang, G. W., Kanner, J. B., Kapadia, S. J., Karki, S., Karvinen, K. S., Kashyap, R., Kasprzack, M., Katsanevas, S., Katsavounidis, E., Katzman, W., Kaufer, S., Kawabe, K., Kawaguchi, K., Kawai, N., Kawasaki, T., Keerthana, N. V., Kefelian, F., Keitel, D., Kennedy, R., Key, J. S., Khalili, F. Y., Khan, H., Khan, I., Khan, S., Khan, Z., Khazanov, E. A., Khursheed, M., Kijbunchoo, N., Kim, C., Kim, J. C., Kim, J., Kim, K., Kim, W., Kim, W. S., Kim, Y. -M., Kimball, C., Kimura, N., King, E. J., King, P. J., Kinley-Hanlon, M., Kirchhoff, R., Kissel, J. S., Kita, N., Kitazawa, H., Kleybolte, L., Klika, J. H., Klimenko, S., Knowles, T. D., Knyazev, E., Koch, P., Koehlenbeck, S. M., Koekoek, G., Kojima, Y., Kokeyama, K., Koley, S., Komori, K., Kondrashov, V., Kong, A. K. H., Kontos, A., Koper, N., Korobko, M., Korth, W. Z., Kotake, K., Kowalska, I., Kozak, D. B., Kozakai, C., Kozu, R., Kringel, V., Krishnendu, N., Krolak, A., Kuehn, G., Kumar, A., Kumar, P., Kumar, R., Kumar, S., Kume, J., Kuo, C. M., Kuo, H. S., Kuo, L., Kuroyanagi, S., Kusayanagi, K., Kutynia, A., Kwak, K., Kwang, S., Lackey, B. D., Lai, K. H., Lam, T. L., Landry, M., Lane, B. B., Lang, R. N., Lange, J., Lantz, B., Lanza, R. K., Lartaux-Vollard, A., Lasky, P. D., Laxen, M., Lazzarini, A., Lazzaro, C., Leaci, P., Leavey, S., Lecoeuche, Y. K., Lee, C. H., Lee, H. K., Lee, H. M., Lee, H. W., Lee, J., Lee, K., Lee, R. K., Lehmann, J., Lenon, A., Leonardi, M., Leroy, N., Letendre, N., Levin, Y., Li, J., Li, K. J. L., Li, T. G. F., Li, X., Lin, C. Y., Lin, F., Lin, F. L., Lin, L. C. C., Linde, F., Linker, S. D., Littenberg, T. B., Liu, G. C., Liu, J., Liu, X., Lo, R. K. L., Lockerbie, N. A., London, L. T., Longo, A., Lorenzini, M., Loriette, V., Lormand, M., Losurdo, G., Lough, J. D., Lousto, C. O., Lovelace, G., Lower, M. E., Luck, H., Lumaca, D., Lundgren, A. P., Luo, L. W., Lynch, R., Ma, Y., Macas, R., Macfoy, S., Macinnis, M., Macleod, D. M., Macquet, A., Magana-Sandoval, F., Zertuche, L. M., Magee, R. M., Majorana, E., Maksimovic, I., Malik, A., Man, N., Mandic, V., Mangano, V., Mansell, G. L., Manske, M., Mantovani, M., Marchesoni, F., Marchio, M., Marion, F., Marka, S., Marka, Z., Markakis, C., Markosyan, A. S., Markowitz, A., Maros, E., Marquina, A., Marsat, S., Martelli, F., Martin, I. W., Martin, R. M., Martynov, D. V., Mason, K., Massera, E., Masserot, A., Massinger, T. J., Masso-Reid, M., Mastrogiovanni, S., Matas, A., Matichard, F., Matone, L., Mavalvala, N., Mazumder, N., Mccann, J. J., Mccarthy, R., Mcclelland, D. E., Mccormick, S., Mcculler, L., Mcguire, S. C., Mciver, J., Mcmanus, D. J., Mcrae, T., Mcwilliams, S. T., Meacher, D., Meadors, G. D., Mehmet, M., Mehta, A. K., Meidam, J., Melatos, A., Mendell, G., Mercer, R. A., Mereni, L., Merilh, E. L., Merzougui, M., Meshkov, S., Messenger, C., Messick, C., Metzdorff, R., Meyers, P. M., Miao, H., Michel, C., Michimura, Y., Middleton, H., Mikhailov, E. E., Milano, L., Miller, A. L., Miller, A., Millhouse, M., Mills, J. C., Milovich-Goff, M. C., Minazzoli, O., Minenkov, Y., Mio, N., Mishkin, A., Mishra, C., Mistry, T., Mitra, S., Mitrofanov, V. P., Mitselmakher, G., Mittleman, R., Miyakawa, O., Miyamoto, A., Miyazaki, Y., Miyo, K., Miyoki, S., Mo, G., Moffa, D., Mogushi, K., Mohapatra, S. R. P., Montani, M., Moore, C. J., Moraru, D., Moreno, G., Morisaki, S., Moriwaki, Y., Mours, B., Mow-Lowry, C. M., Mukherjee, A., Mukherjee, D., Mukherjee, S., Mukund, N., Mullavey, A., Munch, J., Muniz, E. A., Muratore, M., Murray, P. G., Nagano, K., Nagano, S., Nagar, A., Nakamura, K., Nakano, H., Nakano, M., Nakashima, R., Nardecchia, I., Narikawa, T., Naticchioni, L., Nayak, R. K., Negishi, R., Neilson, J., Nelemans, G., Nelson, T. J. N., Nery, M., Neunzert, A., Ng, K. Y., Ng, S., Nguyen, P., Ni, W. T., Nichols, D., Nishizawa, A., Nissanke, S., Nocera, F., North, C., Nuttall, L. K., Obergaulinger, M., Oberling, J., O'Brien, B. D., Obuchi, Y., O'Dea, G. D., Ogaki, W., Ogin, G. H., Oh, J. J., Oh, S. H., Ohashi, M., Ohishi, N., Ohkawa, M., Ohme, F., Ohta, H., Okada, M. A., Okutomi, K., Oliver, M., Oohara, K., Ooi, C. P., Oppermann, P., Oram, R. J., O'Reilly, B., Ormiston, R. G., Ortega, L. F., O'Shaughnessy, R., Oshino, S., Ossokine, S., Ottaway, D. J., Overmier, H., Owen, B. J., Pace, A. E., Pagano, G., Page, M. A., Pai, A., Pai, S. A., Palamos, J. R., Palashov, O., Palomba, C., Pal-Singh, A., Pan, H. -W., Pan, K. C., Pang, B., Pang, H. F., Pang, P. T. H., Pankow, C., Pannarale, F., Pant, B. C., Paoletti, F., Paoli, A., Papa, M. A., Parida, A., Park, J., Parker, W., Pascucci, D., Pasqualetti, A., Passaquieti, R., Passuello, D., Patil, M., Patricelli, B., Pearlstone, B. L., Pedersen, C., Pedraza, M., Pedurand, R., Pele, A., Arellano, F. E. P., Penn, S., Perez, C. J., Perreca, A., Pfeiffer, H. P., Phelps, M., Phukon, K. S., Piccinni, O. J., Pichot, M., Piergiovanni, F., Pillant, G., Pinard, L., Pinto, I., Pirello, M., Pitkin, M., Poggiani, R., Pong, D. Y. T., Ponrathnam, S., Popolizio, P., Porter, E. K., Powell, J., Prajapati, A. K., Prasad, J., Prasai, K., Prasanna, R., Pratten, G., Prestegard, T., Privitera, S., Prodi, G. A., Prokhorov, L. G., Puncken, O., Punturo, M., Puppo, P., Purrer, M., Qi, H., Quetschke, V., Quinonez, P. J., Quintero, E. A., Quitzow-James, R., Raab, F. J., Radkins, H., Radulescu, N., Raffai, P., Raja, S., Rajan, C., Rajbhandari, B., Rakhmanov, M., Ramirez, K. E., Ramos-Buades, A., Rana, J., Rao, K., Rapagnani, P., Raymond, V., Razzano, M., Read, J., Regimbau, T., Rei, L., Reid, S., Reitze, D. H., Ren, W., Ricci, F., Richardson, C. J., Richardson, J. W., Ricker, P. M., Riles, K., Rizzo, M., Robertson, N. A., Robie, R., Robinet, F., Rocchi, A., Rolland, L., Rollins, J. G., Roma, V. J., Romanelli, M., Romano, R., Romel, C. L., Romie, J. H., Rose, K., Rosinska, D., Rosofsky, S. G., Ross, M. P., Rowan, S., Rudiger, A., Ruggi, P., Rutins, G., Ryan, K., Sachdev, S., Sadecki, T., Sago, N., Saito, S., Saito, Y., Sakai, K., Sakai, Y., Sakamoto, H., Sakellariadou, M., Sakuno, Y., Salconi, L., Saleem, M., Samajdar, A., Sammut, L., Sanchez, E. J., Sanchez, L. E., Sanchis-Gual, N., Sandberg, V., Sanders, J. R., Santiago, K. A., Sarin, N., Sassolas, B., Sathyaprakash, B. S., Sato, S., Sato, T., Sauter, O., Savage, R. L., Sawada, T., Schale, P., Scheel, M., Scheuer, J., Schmidt, P., Schnabel, R., Schofield, R. M. S., Schonbeck, A., Schreiber, E., Schulte, B. W., Schutz, B. F., Schwalbe, S. G., Scott, J., Scott, S. M., Seidel, E., Sekiguchi, T., Sekiguchi, Y., Sellers, D., Sengupta, A. S., Sennett, N., Sentenac, D., Sequino, V., Sergeev, A., Setyawati, Y., Shaddock, D. A., Shaffer, T., Shahriar, M. S., Shaner, M. B., Shao, L., Sharma, P., Shawhan, P., Shen, H., Shibagaki, S., Shimizu, R., Shimoda, T., Shimode, K., Shink, R., Shinkai, H., Shishido, T., Shoda, A., Shoemaker, D. H., Shoemaker, D. M., Shyamsundar, S., Siellez, K., Sieniawska, M., Sigg, D., Silva, A. D., Singer, L. P., Singh, N., Singhal, A., Sintes, A. M., Sitmukhambetov, S., Skliris, V., Slagmolen, B. J. J., Slaven-Blair, T. J., Smith, J. R., Smith, R. J. E., Somala, S., Somiya, K., Son, E. J., Sorazu, B., Sorrentino, F., Sotani, H., Souradeep, T., Sowell, E., Spencer, A. P., Srivastava, A. K., Srivastava, V., Staats, K., Stachie, C., Standke, M., Steer, D. A., Steinke, M., Steinlechner, J., Steinlechner, S., Steinmeyer, D., Stevenson, S. P., Stocks, D., Stone, R., Stops, D. J., Strain, K. A., Stratta, G., Strigin, S. E., Strunk, A., Sturani, R., Stuver, A. L., Sudhir, V., Sugimoto, R., Summerscales, T. Z., Sun, L., Sunil, S., Suresh, J., Sutton, P. J., Suzuki, T., Swinkels, B. L., Szczepanczyk, M. J., Tacca, M., Tagoshi, H., Tait, S. C., Takahashi, H., Takahashi, R., Takamori, A., Takano, S., Takeda, H., Takeda, M., Talbot, C., Talukder, D., Tanaka, H., Tanaka, K., Tanaka, T., Tanioka, S., Tanner, D. B., Tapai, M., Martin, E. N. T. S., Taracchini, A., Tasson, J. D., Taylor, R., Telada, S., Thies, F., Thomas, M., Thomas, P., Thondapu, S. R., Thorne, K. A., Thrane, E., Tiwari, S., Tiwari, V., Toland, K., Tomaru, T., Tomigami, Y., Tomura, T., Tonelli, M., Tornasi, Z., Torres-Forne, A., Torrie, C. I., Toyra, D., Travasso, F., Traylor, G., Tringali, M. C., Trovato, A., Trozzo, L., Trudeau, R., Tsang, K. W., Tsang, T. T. L., Tse, M., Tso, R., Tsubono, K., Tsuchida, S., Tsukada, L., Tsuna, D., Tsuzuki, T., Tuyenbayev, D., Uchikata, N., Uchiyama, T., Ueda, A., Uehara, T., Ueno, K., Ueshima, G., Ugolini, D., Unnikrishnan, C. S., Uraguchi, F., Urban, A. L., Ushiba, T., Usman, S. A., Vahlbruch, H., Vajente, G., Valdes, G., Bakel, N., Beuzekom, M., Brand, J. F. J., Broeck, C. V. D., Vander-Hyde, D. C., Schaaf, L., Heijningen, J. V., Putten, M. H. P. M., Veggel, A. A., Vardaro, M., Varma, V., Vass, S., Vasuth, M., Vecchio, A., Vedovato, G., Veitch, J., Veitch, P. J., Venkateswara, K., Venugopalan, G., Verkindt, D., Vetrano, F., Vicere, A., Viets, A. D., Vine, D. J., Vinet, J. -Y., Vitale, S., Vivanco, F. H., Vo, T., Vocca, H., Vorvick, C., Vyatchanin, S. P., Wade, A. R., Wade, L. E., Wade, M., Walet, R., Walker, M., Wallace, L., Walsh, S., Wang, G., Wang, H., Wang, J., Wang, J. Z., Wang, W. H., Wang, Y. F., Ward, R. L., Warden, Z. A., Warner, J., Was, M., Watchi, J., Weaver, B., Wei, L. -W., Weinert, M., Weinstein, A. J., Weiss, R., Wellmann, F., Wen, L., Wessel, E. K., Wessels, P., Westhouse, J. W., Wette, K., Whelan, J. T., Whiting, B. F., Whittle, C., Wilken, D. M., Williams, D., Williamson, A. R., Willis, J. L., Willke, B., Wimmer, M. H., Winkler, W., Wipf, C. C., Wittel, H., Woan, G., Woehler, J., Wofford, J. K., Worden, J., Wright, J. L., Wu, C. M., Wu, D. S., Wu, H. C., Wu, S. R., Wysocki, D. M., Xiao, L., Xu, W. R., Yamada, T., Yamamoto, H., Yamamoto, K., Yamamoto, T., Yancey, C. C., Yang, L., Yap, M. J., Yazback, M., Yeeles, D. W., Yokogawa, K., Yokoyama, J., Yokozawa, T., Yoshioka, T., Yu, H., Yuen, S. H. R., Yuzurihara, H., Yvert, M., Zadrozny, A. K., Zanolin, M., Zeidler, S., Zelenova, T., Zendri, J. -P., Zevin, M., Zhang, J., Zhang, L., Zhang, T., Zhao, C., Zhao, Y., Zhou, M., Zhou, Z., Zhu, X. J., Zhu, Z. H., Zimmerman, A. B., Zucker, M. E., Zweizig, J., Abernathy, M. R., Adams, T., Addesso, P., Adhikari, R. X., Allen, B., Asada, H., Ast, M., Atsuta, S., Aulbert, C., Awai, K., Batch, J. C., Baune, C., Bavigadda, V., Bécsy, B., Beer, C., Belgin, M., Bhagwat, S., Billman, C. R., Biwer, C., Blackman, J., Bock, O., Bohe, A., Braginsky, V. B., Broida, J. E., Buchanan, C. C., Calderón bustillo, J., Capano, C. D., Casanueva diaz, J., Cavaglià, M., Cepeda, C. B., Cerboni baiardi, L., Chmiel, T., Chow, J. H., Chua, A. J. K., Colla, A., Cominsky, L., Canton, T. Dal, D’Antonio, S., Davies, G. S., Day, B., Day, R., De, S., Debreczeni, G., Deléglise, S., Del Pozzo, W., Denker, T., Dergachev, V., De Rosa, Rosario., Derosa, R. T., Devine, R. C., Díaz, M. C., Fiore, L. Di, Giovanni, M. Di, Di Girolamo, T., Lieto, A. Di, Pace, S. Di, Palma, I. Di, Virgilio, A. Di, Dolique, V., Douglas, R., Dovale álvarez, M., Drever, R. W. P., Ducrot, M., Eda, K., Eggenstein, H. -B., Etienne, Z., Everett, R., Factourovich, M., Fehrmann, H., Fernández galiana, A., Forsyth, S. S., Fries, E. M., Fujimoto, M. -K., Gabbard, H., Gehrels, N., Ghosh, Abhirup, Ghosh, Archisman, Glaefke, A., Gondan, L., González, G., Gonzalez castro, J. M., Guo, X., Gushwa, K. E., Hacker, J. J., Hart, M. J., Hartman, M. T., Henry, J., Houston, E. A., Hu, Y. M., Indik, N., Ingram, D. R., Isogai, T., Jawahar, S., Jiménez-Forteza, F., Johnson, W. W., Kagawa, T., Kakizaki, M., Kanemura, S., Kaneyama, M., Kang, G., Kataoka, Y., Kaur, T., Kawamura, S., Kéfélian, F., Kelley, D. B., Kim, H., Kimbrell, S. J., Klein, B., Krämer, C., Krishnan, B., Królak, A., Kumar, Rahul, Kumar, Rakesh, Kuroda, K., Kuwahara, Y., Lebigot, E. O., Leong, J. R., Libson, A., Lombardi, A. L., Lord, J. E., Lück, H., Machenschalk, B., Magaña-Sandoval, F., Malvezzi, V., Mano, S., Márka, S., Márka, Z., Martellini, L., Matsumoto, N., Matsushima, F., Mcgrath, C., Mcintyre, G., Mendoza-Gandara, D., Mezzani, F., Miller, B. B., Ming, J., Mirshekari, S., Miyamoto, T., Moggi, A., Mohan, M., Moore, B. C., Morii, W., Morriss, S. R., Mueller, G., Muir, A. W., Mukherjee, Arunava, Muniz, E. A. M., Mytidis, A., Nakamura, T., Nakano, Masaya, Nakano, Masayuki, Nakao, K., Napier, K., Neri, M., Newport, J. M., Newton, G., Nguyen, T. T., Ni, W. -T., Nielsen, A. B., Nitz, A., Noack, A., Nolting, D., Normandin, M. E. N., Ochsner, E., Oelker, E., Ono, K., Ono, Y., Oram, Richard J., O’Reilly, B., O’Shaughnessy, R., Page, J., Pan, H., Paris, H. R., Pekowsky, L., Peña arellano, F. E., Perri, L. M., Pierro, V., Pinto, I. M., Poe, M., Post, A., Pratt, J. W. W., Predoi, V., Prijatelj, M., Principe, M., Pürrer, M., Qin, J., Qiu, S., Rabeling, D. S., Re, V., Rew, H., Reyes, S. D., Rhoades, E., Rosińska, D., Rüdiger, A., Sadeghian, L., Saijo, M., Salemi, F., Sampson, L. M., Sasaki, Y., Saulson, P. R., Sawadsky, A., Schmidt, E., Schmidt, J., Schönbeck, A., Schuette, D., Shaffer, T. J., Shapiro, B., Sheperd, A., Shibata, M., Shikano, Y., Siemens, X., Singer, A., Singh, A., Singh, R., Smith, B., Staley, A., Stephens, B. C., Straniero, N., Sugimoto, Y., Szczepańczyk, M. J., Takada, S., Tápai, M., Tatsumi, D., Theeg, T., Thomas, E. G., Tippens, T., Tokmakov, K. V., Tomlinson, C., Töyrä, D., Trifirò, D., Trinastic, J., Turconi, M., Ueki, S., van Bakel, N., van Beuzekom, M., van den Brand, J. F. J., Van Den Broeck, C., van der Schaaf, L., van Heijningen, J. V., van Putten, M. H. P. M., van Veggel, A. A., Vasúth, M., Viceré, A., Vinciguerra, S., Voss, D. V., Vousden, W. D., Wakamatsu, T., Wang, M., Wang, Y., Weßels, P., Westphal, T., Williams, R. D., Wu, G., Yam, W., Yano, K., Yoon, T. H., Zadrożny, A., Zangrando, L., Zhang, M., Zhang, Y., and Zhu, S. J.
- Subjects
neutron star: binary ,EVENTS GW150914 ,Gravitational-wave observatory ,Physics and Astronomy (miscellaneous) ,Astronomy ,Binary number ,Astrophysics ,detector: network ,Review Article ,BLACK-HOLE BINARIES ,01 natural sciences ,General Relativity and Quantum Cosmology ,localization ,Physics, Particles & Fields ,Gravitational waves ,Gravitational-wave detectors ,Electromagnetic counterparts ,Data analysis ,Observatory ,Gravitational-wave detector ,NEUTRON-STAR ,LIGO ,010303 astronomy & astrophysics ,ELECTROMAGNETIC SIGNALS ,QC ,QB ,media_common ,Settore FIS/01 ,Physics ,High Energy Astrophysical Phenomena (astro-ph.HE) ,NUCLEOSYNTHESIS ,GAMMA-RAY BURSTS ,star merger rate ,COMPACT BINARIES ,Detector ,Astrophysics::Instrumentation and Methods for Astrophysics ,Data analysi ,Physical Sciences ,Physique des particules élémentaires ,[PHYS.GRQC]Physics [physics]/General Relativity and Quantum Cosmology [gr-qc] ,Astrophysics - High Energy Astrophysical Phenomena ,Gravitational wave ,BLACK-HOLE MERGERS ,data analysis method ,LONG-TERM ,media_common.quotation_subject ,Astrophysics::High Energy Astrophysical Phenomena ,FOS: Physical sciences ,counterparts ,General Relativity and Quantum Cosmology (gr-qc) ,Astrophysics::Cosmology and Extragalactic Astrophysics ,MASS ,lcsh:Atomic physics. Constitution and properties of matter ,Electromagnetic counterpart ,Gravitational-wave astronomy ,electromagnetic field: production ,binary: coalescence ,SEARCH ,evolution ,0103 physical sciences ,KAGRA ,RATES ,Luminosity distance ,Astrophysics::Galaxy Astrophysics ,Science & Technology ,IDENTIFICATION ,010308 nuclear & particles physics ,Physique ,COUNTERPART ,gravitational radiation ,black hole: mass ,binary: compact ,gravitational radiation detector ,EVOLUTION ,lcsh:QC170-197 ,Electromagnetic ,detector: sensitivity ,VIRGO ,black hole: binary ,Physics and Astronomy ,Sky ,Intermediate-mass black hole ,STAR MERGER RATE ,gravitational radiation: emission ,SWIFT FOLLOW-UP - Abstract
We present our current best estimate of the plausible observing scenarios for the Advanced LIGO, Advanced Virgo and KAGRA gravitational-wave detectors over the next several years, with the intention of providing information to facilitate planning for multi-messenger astronomy with gravitational waves. We estimate the sensitivity of the network to transient gravitational-wave signals for the third (O3), fourth (O4) and fifth observing (O5) runs, including the planned upgrades of the Advanced LIGO and Advanced Virgo detectors. We study the capability of the network to determine the sky location of the source for gravitational-wave signals from the inspiral of binary systems of compact objects, that is binary neutron star, neutron star–black hole, and binary black hole systems. The ability to localize the sources is given as a sky-area probability, luminosity distance, and comoving volume. The median sky localization area (90% credible region) is expected to be a few hundreds of square degrees for all types of binary systems during O3 with the Advanced LIGO and Virgo (HLV) network. The median sky localization area will improve to a few tens of square degrees during O4 with the Advanced LIGO, Virgo, and KAGRA (HLVK) network. During O3, the median localization volume (90% credible region) is expected to be on the order of 105,106,107Mpc3 for binary neutron star, neutron star–black hole, and binary black hole systems, respectively. The localization volume in O4 is expected to be about a factor two smaller than in O3. We predict a detection count of 1-1+12(10-10+52) for binary neutron star mergers, of 0-0+19(1-1+91) for neutron star–black hole mergers, and 17-11+22(79-44+89) for binary black hole mergers in a one-calendar-year observing run of the HLV network during O3 (HLVK network during O4). We evaluate sensitivity and localization expectations for unmodeled signal searches, including the search for intermediate mass black hole binary mergers., 0, info:eu-repo/semantics/inPress
- Published
- 2018
- Full Text
- View/download PDF
3. Silicon Carbide Nanostructures as Potential Carbide Material for Electrochemical Supercapacitors: A Review.
- Author
-
Ojha GP, Kang GW, Kuk YS, Hwang YE, Kwon OH, Pant B, Acharya J, Park YW, and Park M
- Abstract
Silicon carbide (SiC) is a very promising carbide material with various applications such as electrochemical supercapacitors, photocatalysis, microwave absorption, field-effect transistors, and sensors. Due to its enticing advantages of high thermal stability, outstanding chemical stability, high thermal conductivity, and excellent mechanical behavior, it is used as a potential candidate in various fields such as supercapacitors, water-splitting, photocatalysis, biomedical, sensors, and so on. This review mainly describes the various synthesis techniques of nanostructured SiC (0D, 1D, 2D, and 3D) and its properties. Thereafter, the ongoing research trends in electrochemical supercapacitor electrodes are fully excavated. Finally, the outlook of future research directions, key obstacles, and possible solutions are emphasized.
- Published
- 2022
- Full Text
- View/download PDF
4. Health-related quality of life using WHODAS 2.0 and associated factors 1 year after stroke in Korea: a multi-centre and cross-sectional study.
- Author
-
Lee HJ, Song JK, Moon J, Kim K, Park HK, Kang GW, Shin JH, Kang J, Kim BG, Lee YH, Jeong HS, Heeyoung L, Lee WK, Kim S, and Park YK
- Subjects
- Humans, Activities of Daily Living, Cross-Sectional Studies, Quality of Life, Dysarthria, Hemiplegia, Republic of Korea epidemiology, Disability Evaluation, Stroke epidemiology, Brain Ischemia
- Abstract
Background: Little is known about the self-perceived level of disability of stroke survivors in the community. We aimed to characterise Health-related quality of life (HRQoL) 1 year after stroke and investigate how sociodemographic and stroke-related factors and medical adherence explain the self-perceived level of disability in a Korean stroke population., Methods: This was a multicentre cross-sectional study. A total of 382 ischaemic stroke survivors at 1 year after onset from 11 university hospitals underwent a one-session assessment, including socioeconomic variables, the modified Rankin Scale (mRS), various neurological sequelae, the Morisky, Green and Levin-Medication Adherence Questionnaire (MGL), and the World Health Organization Disability Assessment Schedule 2.0 (WHODAS 2.0) 36-items. The relationship between disability and different variables was analysed using ordinal logistic regression., Results: The prevalence of disability based on global WHODAS 2.0 was 62.6% (mild, 41.6%; moderate, 16.0%; severe, 5.0%). The prevalence of severe disability was higher in participation in society (16.8%) and getting around (11.8%) than in other domains. Low MGL- motivation was the only factor determining a significant association between all six domains of disability after adjustment. Different predictors for specific domains were age, mRS, dysarthria, trouble seeing, cognition problems, and MGL-motivation for understanding and communicating; age, recurrent stroke, mRS, hemiplegia, facial palsy, general weakness, and MGL-motivation for getting around; age, education, mRS, hemiplegia, and MGL-motivation for self-care; education, recurrent stroke, hemiplegia, dysarthria, and MGL-motivation for getting along with people; age, education, income, mRS, hemiplegia, dysarthria, MGL-knowledge, and MGL-motivation for life activities; living without a spouse, mRS, hemiplegia, dysarthria, trouble seeing, cognition problems, general weakness, and MGL-motivation for participation in society., Conclusions: Self-perceived disability according to the WHODAS 2.0 at 1 year after stroke was highly prevalent. Each disability domain showed a different prevalence and associated factors. Interventions promoting medical adherence to motivation seemed to help achieve high HRQoL in all domains., (© 2022. The Author(s).)
- Published
- 2022
- Full Text
- View/download PDF
5. Heritability of maxillary dental cephalometric variables among monozygotic twins, dizygotic twins and their siblings.
- Author
-
Kang GW, Kim YH, Hong C, Woo S, Sung J, Song YM, Shin JW, and Chae HS
- Subjects
- Cephalometry, Female, Humans, Male, Maxilla diagnostic imaging, Siblings, Twins, Dizygotic genetics, Twins, Monozygotic genetics
- Abstract
Objectives: The purpose of this study was to investigate the heritability of dental cephalometric variables by analyzing vertical linear measurements and angular measurements of the upper incisor, canine, and first molar., Materials and Methods: Among the 553 Korean patients who participated in twin studies conducted at Samsung Medical Center, 150 patients had their lateral cephalometric radiograph data included in this study. The group was comprised of 36 monozygotic (MZ) twins (males, 16 pairs; females, 20 pairs), 13 dizygotic (DZ) twins (males, 7 pairs; females, 6 pairs), and 26 same-sex sibling pairs (males, 11 pairs; females, 15 pairs). All patients were over 20 years old with a mean age of 39.75 years. Lateral cephalometric diagrams and linear measurements (6 vertical factors, 6 horizontal factors) were taken. Three axial planes were measured for each tooth; intraclass correlation coefficients (ICCs) were obtained for each group and heritability was calculated using Falconer's method., Results: ICCs of vertical linear measurements (average 0.837, P < 0.01) and the tooth axis of the central incisor and canine (average 0.679, P < 0.001) were higher in the MZ group compared to the DZ and sibling groups; thus, these variables showed high heritability., Conclusions: Orthodontic treatment aiming to alter the tooth axis of the maxillary central incisor or canine or other vertical factors with greater heritability can be difficult, requiring strategic treatment planning to achieve desired treatment outcome and stability., Clinical Relevance: The active early treatment to gain tooth eruption space can lead to normal tooth position., (© 2022. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.)
- Published
- 2022
- Full Text
- View/download PDF
6. Photobiomodulation regulates adult neurogenesis in the hippocampus in a status epilepticus animal model.
- Author
-
Hong N, Kang GW, Park JO, Chung PS, Lee MY, and Ahn JC
- Subjects
- Animals, Disease Models, Animal, Hippocampus, Seizures radiotherapy, Neurogenesis, Status Epilepticus radiotherapy
- Abstract
Status epilepticus (SE) refers to a single seizure that lasts longer than typical seizures or a series of consecutive seizures. The hippocampus, which is vulnerable to the effects of SE, has a critical role in memory storage and retrieval. The trisynaptic loop in the hippocampus connects the substructures thereof, namely the dentate gyrus (DG), CA3, and CA1. In an animal model of SE, abnormal neurogenesis in the DG and aberrant neural network formation result in sequential neural degeneration in CA3 and CA1. Photobiomodulation (PBM) therapy, previously known as low-level laser (light) therapy (LLLT), is a novel therapy for the treatment of various neurological disorders including SE. However, the effects of this novel therapeutic approach on the recovery process are poorly understood. In the present study, we found that PBM transformed SE-induced abnormal neurogenesis to normal neurogenesis. We demonstrated that PBM plays a key role in normal hippocampal neurogenesis by enhancing the migration of maturing granular cells (early neuronal cells) to the GCL, and that normal neurogenesis induced by PBM prevents SE-induced hippocampal neuronal loss in CA1. Thus, PBM is a novel approach to prevent seizure-induced neuronal degeneration, for which light devices may be developed in the future., (© 2022. The Author(s).)
- Published
- 2022
- Full Text
- View/download PDF
7. Macropinocytosis is an alternative pathway of cysteine acquisition and mitigates sorafenib-induced ferroptosis in hepatocellular carcinoma.
- Author
-
Byun JK, Lee S, Kang GW, Lee YR, Park SY, Song IS, Yun JW, Lee J, Choi YK, and Park KG
- Subjects
- Animals, Carcinoma, Hepatocellular pathology, Cysteine pharmacology, Female, Humans, Liver Neoplasms pathology, Male, Mice, Protein Kinase Inhibitors pharmacology, Sorafenib pharmacology, Carcinoma, Hepatocellular complications, Carcinoma, Hepatocellular drug therapy, Cysteine therapeutic use, Ferroptosis drug effects, Liver Neoplasms complications, Liver Neoplasms drug therapy, Pinocytosis drug effects, Protein Kinase Inhibitors therapeutic use, Sorafenib therapeutic use
- Abstract
Background: Macropinocytosis, an important nutrient-scavenging pathway in certain cancer cells, allows cells to compensate for intracellular amino acid deficiency under nutrient-poor conditions. Ferroptosis caused by cysteine depletion plays a pivotal role in sorafenib responses during hepatocellular carcinoma (HCC) therapy. However, it is not known whether macropinocytosis functions as an alternative pathway to acquire cysteine in sorafenib-treated HCC, and whether it subsequently mitigates sorafenib-induced ferroptosis. This study aimed to investigate whether sorafenib drives macropinocytosis induction, and how macropinocytosis confers ferroptosis resistance on HCC cells., Methods: Macropinocytosis, both in HCC cells and HCC tissues, was evaluated by measuring TMR-dextran uptake or lysosomal degradation of DQ-BSA, and ferroptosis was evaluated via C11-BODIPY fluorescence and 4-HNE staining. Sorafenib-induced ferroptosis and macropinocytosis were validated in tumor tissues taken from HCC patients who underwent ultrasound-guided needle biopsy., Results: Sorafenib increased macropinocytosis in human HCC specimens and xenografted HCC tissues. Sorafenib-induced mitochondrial dysfunction was responsible for activation of PI3K-RAC1-PAK1 signaling, and amplified macropinocytosis in HCC. Importantly, macropinocytosis prevented sorafenib-induced ferroptosis by replenishing intracellular cysteine that was depleted by sorafenib treatment; this rendered HCC cells resistant to sorafenib. Finally, inhibition of macropinocytosis by amiloride markedly enhanced the anti-tumor effect of sorafenib, and sensitized resistant tumors to sorafenib., Conclusion: In summary, sorafenib induced macropinocytosis, which conferred drug resistance by mitigating sorafenib-induced ferroptosis. Thus, targeting macropinocytosis is a promising therapeutic strategy to facilitate ferroptosis-based therapy for HCC., (© 2022. The Author(s).)
- Published
- 2022
- Full Text
- View/download PDF
8. Trend of lung cancer surgery, hospital selection, and survival between 2005 and 2016 in South Korea.
- Author
-
Kim D, Kang GW, Jang H, Cho JY, Yang B, Yang HC, and Hwang J
- Subjects
- Adult, Aged, Aged, 80 and over, Female, Humans, Male, Middle Aged, Republic of Korea, Young Adult, Choice Behavior, Hospitals trends, Lung Neoplasms surgery, Pneumonectomy trends, Thoracic Surgical Procedures trends
- Abstract
Background: Studies on the clinical implication of hospital selection for patients with lung cancer are few. Therefore, this study aimed to analyze 2005-2016 data from the Korean national database to assess annual trends of lung cancer surgery and clinical outcomes according to hospital selection., Methods: Data of 212 554 patients with lung cancer who underwent upfront surgery were screened. Trends according to sex, age, residence, and income were examined. Descriptive statistics were performed, and p
trend values were estimated. The association between survival and hospital selection was assessed using the log-rank test. A multivariate Cox regression analysis was also performed., Results: A total of 49 021 patients were included in this study. Surgery was prevalent among men, patients aged 61-75 years, capital area residents, and high-income patients. However, with the increasing rate of surgery among women, patients aged ≥76 years, city residents, and middle-income patients, the current distribution of lung cancer surgery could change. The rate of lobectomy among these groups increased. All patients, except those in capital areas, preferred a hospital outside their area of residence (HOR); the number of patients with this tendency also increased. However, this trend was not observed among low-income patients and those aged ≥76 years. There were significant differences in survival according to hospital selection., Conclusions: The trend of lung cancer surgery is changing. The current medical system is effective in providing lobectomy for patients including women, aged ≥76 years, city residents, and middle-income. Increasing tendency to choose an HOR requires further study., (© 2021 The Authors. Thoracic Cancer published by China Lung Oncology Group and John Wiley & Sons Australia, Ltd.)- Published
- 2022
- Full Text
- View/download PDF
9. Chasing the structural diversity of the transcription regulator Mycobacterium tuberculosis HigA2.
- Author
-
Richardson W, Kang GW, Lee HJ, Kwon KM, Kim S, and Kim HJ
- Abstract
Transcription factors are the primary regulators of gene expression and recognize specific DNA sequences under diverse physiological conditions. Although they are vital for many important cellular processes, it remains unclear when and how transcription factors and DNA interact. The antitoxin from a toxin-antitoxin system is an example of negative transcriptional autoregulation: during expression of the cognate toxin it is suppressed through binding to a specific DNA sequence. In the present study, the antitoxin HigA2 from Mycobacterium tuberculosis M37Rv was structurally examined. The crystal structure of M. tuberculosis HigA2 comprises three sections: an N-terminal autocleavage region, an α-helix bundle which contains an HTH motif, and a C-terminal β-lid. The N-terminal region is responsible for toxin binding, but was shown to cleave spontaneously in its absence. The HTH motif performs a key role in DNA binding, with the C-terminal β-lid influencing the interaction by mediating the distance between the motifs. However, M. tuberculosis HigA2 exhibits a unique coordination of the HTH motif and no DNA-binding activity is detected. Three crystal structures of M. tuberculosis HigA2 show a flexible alignment of the HTH motif, which implies that the motif undergoes structural rearrangement to interact with DNA. This study reveals the molecular mechanisms of how transcription factors interact with partner proteins or DNA., (© William Richardson et al. 2021.)
- Published
- 2021
- Full Text
- View/download PDF
10. Descriptive or injunctive: How do restaurant customers react to the guidelines of COVID-19 prevention measures? The role of psychological reactance.
- Author
-
Kang GW, Piao ZZ, and Ko JY
- Abstract
In this study, we employed an experimental design to empirically test how restaurant customers react differently to normative appeals (descriptive vs. injunctive) relating to COVID-19 prevention measures through freedom threat and negative cognition. We conducted t -tests, serial mediation, moderation, and moderated serial mediation analysis to test the hypotheses using SPSS 23.0 and PROCESS macro v.3.5 (model 6 and model 85). Injunctive normative appeal causes an increase in freedom and a less favorable attitude than descriptive normative appeals. The findings also demonstrate the serial-mediated effect of freedom threat and negative cognition on attitude. Furthermore, the effectiveness of normative appeals depends on an individual's age. This study contributes to the academic literature on hospitality by applying psychological reactance theory and testing the model within a restaurant context. It also discusses the implications of its findings for consumers and restaurant managers., (© 2021 Elsevier Ltd. All rights reserved.)
- Published
- 2021
- Full Text
- View/download PDF
11. Short-term outcomes of pediatric laparoscopic inguinal hernia repair in Korea based on Korean Health Insurance Big Data: 2011-2015.
- Author
-
Park JW, Jang HY, and Kang GW
- Subjects
- Child, Databases, Factual statistics & numerical data, Humans, Laparoscopy statistics & numerical data, Republic of Korea epidemiology, Retrospective Studies, Treatment Outcome, Hernia, Inguinal epidemiology, Hernia, Inguinal surgery, Herniorrhaphy methods, Herniorrhaphy statistics & numerical data
- Abstract
Purpose: For pediatric inguinal hernia repairs (IHRs), open IHR (high ligation) has long been a gold standard. Recently laparoscopic IHR (LIHR) was introduced as a new treatment modality and has been performed more frequently in Korea. Unlike adults, LIHR in children is still controversial. In the present study, we investigate the short-term outcomes of pediatric LIHR in Korea using nationwide inpatient data., Methods: We analyzed clinical practice for IHRs from 2011 to 2015 using Korean Health Insurance Review and Assessment Service-National Inpatient Sample., Results: A total of 5281 patients 15 years old or younger underwent 5356 IHRs: 4507 OIHRs and 849 LIHRs. M:F ratio was 2.4:1. The proportion of LIHRs was only 1.8% at the beginning but had been continuously increased up to 29.8% at the end of the study period. LIHRs were closely related to synchronous bilateral inguinal hernia repairs (SBIHRs). Overall, SBIHRs were performed in 10.9% of open and 49.2% of LIHRs. Metachronous contralateral IHRs (MCIHRs) after initial unilateral IHRs were significantly more frequent after OIHRs (1.7%, 69/3, 951) than after LIHRs (0.2%, 1/427). Recurrence rate per side during study period was 0.1% (6/4, 993) after OIHRs and 0.2% (2/1, 259) after LIHRs, respectively (statistically insignificant)., Conclusion: Nationwide inpatient data showed that LIHRs in pediatric patients had recently been increasingly performed in Korea. LIHRs facilitated SBIHRs, which, in turn, decreased the needs of MCIHRs. However limited numbers of patients might actually have benefited from them. Early recurrence after primary IHRs in children is quite low regardless of way of approach.
- Published
- 2021
- Full Text
- View/download PDF
12. Disparities in the Diagnosis, Treatment, and Survival Rate of Cervical Cancer among Women with and without Disabilities.
- Author
-
Choi JY, Yeob KE, Hong SH, Kim SY, Jeong EH, Shin DW, Park JH, Kang GW, Kim HS, Park JH, and Kawachi I
- Subjects
- Adult, Databases, Factual, Female, Humans, Middle Aged, Odds Ratio, Proportional Hazards Models, Registries, Republic of Korea, Retrospective Studies, Survival Rate, Uterine Cervical Neoplasms mortality, Persons with Disabilities statistics & numerical data, Early Detection of Cancer statistics & numerical data, Healthcare Disparities statistics & numerical data, Uterine Cervical Neoplasms diagnosis, Uterine Cervical Neoplasms therapy
- Abstract
Introduction: Not much is known regarding the disparities in cancer care between women with and without disabilities., Objectives: The aim of this study was to investigate the potential disparities in the diagnosis, treatment, and survival of women with cervical cancer with and without disabilities., Methods: We performed a retrospective cohort study and linked the National Disability Database, Korean Central Cancer Registry, and Korean National Health Insurance claims database. Charlson comorbidity index was used for adjusting the comorbidity. The study population comprised 3 185 women with disabilities (physical/brain, communication, mental, cardiopulmonary, and other impairment) who were diagnosed with cervical cancer and 13 582 age- and sex-matched women without disability who were diagnosed with cervical cancer for comparison., Results: Distant metastatic stage (7.7% vs 3.7%) and unknown stage (16.1% vs 7.0%) were more common in cervical cancer women with grade 1 disabilities, compared with women without disabilities. Women with cervical cancer with disabilities were less likely to undergo surgery (adjusted odds ratio (aOR) 0.81, 95% confidence interval (CI) 0.73-0.90) or chemotherapy (aOR 0.86, 95% CI 0.77-0.97). Lower rate of surgery was more evident in patients with physical/brain impairment (aOR 0.46, 95% CI 0.37-0.58) and severe mental impairment (aOR 0.57, 95% CI 0.41-0.81). The overall mortality risk was also higher in patients with disabilities (adjusted hazard ratio (aHR) 1.36, 95% CI 1.25-1.48)., Conclusion: Women with cervical cancer with disabilities, especially with severe disabilities, were diagnosed at later stages, received less treatment, and had higher mortality rates, compared with patients who lacked disabilities. Social support and policies, along with education for women with disabilities, their families, and healthcare professionals, are needed to improve these disparities.
- Published
- 2021
- Full Text
- View/download PDF
13. Evaluation of changes in anesthetic methods for cesarean delivery: an analysis for 5 years using the big data of the Korean Health Insurance Review and Assessment Service.
- Author
-
Park JI, Park SH, Kang MS, Kang GW, and Kim ST
- Abstract
Background: As an anesthesia induced during cesarean section, spinal anesthesia is preferred over general and epidural anesthesia. This study aimed to review the trend of anesthetic methods for cesarean section based on data obtained from the Korean Health Insurance Review and Assessment Service from 2013 to 2018., Methods: The anesthetic methods were analyzed in 753,285 parturients who underwent a cesarean section in Korea from 2013 to 2018. We determined the association between each anesthetic method and hospital type and maternal and fetal factors. We also evaluated whether the anesthetic method was associated with the parturients' length of hospital stay., Results: General anesthesia, spinal anesthesia, and epidural anesthesia were induced in 28.8%, 47.7%, and 23.6% of parturients from 2013 to 2018, respectively. Trend analyses showed that spinal anesthesia increased from 40.0% in 2013 to 53.7% in 2018. The opposite trend applied to general anesthesia, decreasing from 37.1% in 2013 to 22.2% in 2018. The factors that were significantly associated with the anesthetic method were parturient's parity, emergency condition, gestational age, and fetal weight. The type of hospital, parturient's age, and multiple birth were also associated with the anesthetic methods. There was a strong association between general anesthesia and hospital stay longer than 7 days., Conclusions: Spinal anesthesia is currently the main anesthetic method used for cesarean delivery, and the rate of spinal anesthesia is gradually increasing in Korea., Competing Interests: CONFLICTS OF INTEREST No potential conflict of interest relevant to this article was reported., (Copyright © the Korean Society of Anesthesiologists, 2020.)
- Published
- 2020
- Full Text
- View/download PDF
14. Hemodialysis with Cohort Isolation to Prevent Secondary Transmission during a COVID-19 Outbreak in Korea.
- Author
-
Cho JH, Kang SH, Park HC, Kim DK, Lee SH, Do JY, Park JW, Kim SN, Kim MS, Jin K, Kang GW, Park SH, Kim YL, and Lee YK
- Subjects
- Adult, COVID-19, Chi-Square Distribution, Cohort Studies, Comorbidity, Coronavirus Infections diagnosis, Coronavirus Infections therapy, Female, Health Personnel statistics & numerical data, Humans, Incidence, Infection Control organization & administration, Kidney Failure, Chronic diagnosis, Kidney Failure, Chronic epidemiology, Male, Middle Aged, Occupational Health, Pandemics, Patient Safety, Pneumonia, Viral diagnosis, Pneumonia, Viral therapy, Program Evaluation, Renal Dialysis statistics & numerical data, Republic of Korea epidemiology, Retrospective Studies, Risk Assessment, Secondary Prevention organization & administration, Statistics, Nonparametric, Survival Rate, Coronavirus Infections epidemiology, Disease Outbreaks, Disease Transmission, Infectious prevention & control, Kidney Failure, Chronic therapy, Patient Isolation organization & administration, Pneumonia, Viral epidemiology, Renal Dialysis methods
- Abstract
Background: Health care-associated infections during previous coronavirus epidemics involving severe acute respiratory syndrome and Middle East respiratory syndrome resulted from human-to-human transmission in hemodialysis (HD) facilities. The effect of a strategy of HD with cohort isolation-separate dialysis sessions for close contacts of patients with confirmed coronavirus disease 2019 (COVID-19)-on the prevention of secondary transmission of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in HD units is unknown., Methods: Our multicenter cohort study of an HD with cohort isolation strategy enrolled close contacts of patients with confirmed COVID-19, including patients on HD and health care workers in HD units. Close contacts had been identified by epidemiologic investigation and tested negative on an immediate screening test for SARS-CoV-2., Results: As of March 14, 11 patients on HD and 7 health care workers from 11 HD centers were diagnosed as having COVID-19. The immediate screening test was performed in 306 people, and among them, 302 close contacts with negative test results were enrolled. HD with cohort isolation was performed among all close contacts for a median of 14 days in seven centers. During cohort isolation, nine patients showed symptoms but tested negative for SARS-CoV-2. Two health care workers in the HD units (0.66% of the total group) were diagnosed at the termination test for SARS-CoV-2., Conclusions: The transmission of COVID-19 can be controlled without closure of HD centers by implementing preemptive activities, including early detection with rapid testing, cohort isolation, collaboration between institutions, and continuous monitoring of infection. Our strategy and experience may provide helpful guidance for circumstances involving the rapid spread of infectious diseases such as COVID-19., (Copyright © 2020 by the American Society of Nephrology.)
- Published
- 2020
- Full Text
- View/download PDF
15. A review of South Korean Alloplasta Förster (Hymenoptera: Ichneumonidae: Banchinae) with description of a new species.
- Author
-
Kang GW, Kolarov J, and Lee JW
- Subjects
- Animals, Male, Republic of Korea, Hymenoptera
- Abstract
South Korean Alloplasta species were examined in this study. Prior to this study, only A. longipetiolaris of this genus was previously known from South Korea. Four species are new records, A. kuslitzky, A. nigripes, A. maruyamana and A. subgrisea, and A. brevipetiolaris sp. nov. is described as new to science. Furthermore males of two species, A. kuslitzky and A. subgrisea, are described for the first time. An illustrated identification key is provided for the Alloplasta species known from South Korea.
- Published
- 2020
- Full Text
- View/download PDF
16. Efficacy and Safety of CKD-11101 (Proposed Biosimilar of Darbepoetin-Alfa) Compared with Darbepoetin-Alfa in Patients on Hemodialysis: A Randomized, Double-Blinded, Parallel-Group Phase III Study.
- Author
-
Kim Y, Park SK, Cho WY, Joo KW, Shin SK, Kim DJ, Kim YL, Son SH, Chung W, Lee KY, Park SK, Kim JK, Kim SW, Kang DH, Kim JK, Jeon JS, Lee KW, Lee CH, Oh DJ, An WS, Lee JS, Kang GW, Do JY, Lee JP, and Jin K
- Subjects
- Adult, Double-Blind Method, Drug-Related Side Effects and Adverse Reactions etiology, Female, Hemoglobins metabolism, Humans, Male, Middle Aged, Renal Dialysis methods, Renal Insufficiency, Chronic metabolism, Biosimilar Pharmaceuticals adverse effects, Biosimilar Pharmaceuticals therapeutic use, Darbepoetin alfa adverse effects, Darbepoetin alfa therapeutic use, Epoetin Alfa adverse effects, Epoetin Alfa pharmacology, Renal Insufficiency, Chronic drug therapy
- Abstract
Background: Darbepoetin-alfa is an erythropoiesis-stimulating agent (ESA) with a long elimination half-life that achieves better hemoglobin (Hb) stability than short-acting ESAs., Objective: We aimed to evaluate the efficacy and safety of intravenous CKD-11101 (a biosimilar of darbepoetin-alfa) compared with those of darbepoetin-alfa in hemodialysis patients., Methods: The study was performed in 24 centers in Korea between June 2015 and June 2017. The study subjects were randomized in a double-blind manner. The follow-up duration was 24 weeks, which consisted of 20 weeks of maintenance and 4 weeks of evaluation period. All patients underwent a stabilization period to achieve a target baseline Hb of 10-12 g/dL before randomization. Following randomization, patients received darbepoetin-alfa or CKD-11101 weekly or biweekly., Results: A total of 403 patients were randomized into two groups, and a total of 325 patients (80.6%) completed the investigation. The differences between the two groups in terms of change in the average Hb level from baseline to evaluation were not significant. The average administered dose of ESA was similar between the groups. There was no difference in the proportion of patients who maintained the target Hb during the evaluation period [60.4% vs. 66.2% in the CKD-11101 and darbepoetin-alfa groups, respectively (p = 0.3038)]. In addition, the safety analysis, consisting of adverse events and adverse drug reactions, showed comparable results between the two groups., Conclusion: The changes in the level of Hb, dose of erythropoietin, and achievement rate of the target Hb during the study period were comparable between the groups. CKD-11101 has an equivalent efficacy and safety compared with darbepoetin-alfa in patients undergoing hemodialysis.
- Published
- 2020
- Full Text
- View/download PDF
17. Prospects for observing and localizing gravitational-wave transients with Advanced LIGO, Advanced Virgo and KAGRA.
- Author
-
Abbott BP, Abbott R, Abbott TD, Abraham S, Acernese F, Ackley K, Adams C, Adya VB, Affeldt C, Agathos M, Agatsuma K, Aggarwal N, Aguiar OD, Aiello L, Ain A, Ajith P, Akutsu T, Allen G, Allocca A, Aloy MA, Altin PA, Amato A, Ananyeva A, Anderson SB, Anderson WG, Ando M, Angelova SV, Antier S, Appert S, Arai K, Arai K, Arai Y, Araki S, Araya A, Araya MC, Areeda JS, Arène M, Aritomi N, Arnaud N, Arun KG, Ascenzi S, Ashton G, Aso Y, Aston SM, Astone P, Aubin F, Aufmuth P, AultONeal K, Austin C, Avendano V, Avila-Alvarez A, Babak S, Bacon P, Badaracco F, Bader MKM, Bae SW, Bae YB, Baiotti L, Bajpai R, Baker PT, Baldaccini F, Ballardin G, Ballmer SW, Banagiri S, Barayoga JC, Barclay SE, Barish BC, Barker D, Barkett K, Barnum S, Barone F, Barr B, Barsotti L, Barsuglia M, Barta D, Bartlett J, Barton MA, Bartos I, Bassiri R, Basti A, Bawaj M, Bayley JC, Bazzan M, Bécsy B, Bejger M, Belahcene I, Bell AS, Beniwal D, Berger BK, Bergmann G, Bernuzzi S, Bero JJ, Berry CPL, Bersanetti D, Bertolini A, Betzwieser J, Bhandare R, Bidler J, Bilenko IA, Bilgili SA, Billingsley G, Birch J, Birney R, Birnholtz O, Biscans S, Biscoveanu S, Bisht A, Bitossi M, Bizouard MA, Blackburn JK, Blair CD, Blair DG, Blair RM, Bloemen S, Bode N, Boer M, Boetzel Y, Bogaert G, Bondu F, Bonilla E, Bonnand R, Booker P, Boom BA, Booth CD, Bork R, Boschi V, Bose S, Bossie K, Bossilkov V, Bosveld J, Bouffanais Y, Bozzi A, Bradaschia C, Brady PR, Bramley A, Branchesi M, Brau JE, Briant T, Briggs JH, Brighenti F, Brillet A, Brinkmann M, Brisson V, Brockill P, Brooks AF, Brown DA, Brown DD, Brunett S, Buikema A, Bulik T, Bulten HJ, Buonanno A, Buskulic D, Buy C, Byer RL, Cabero M, Cadonati L, Cagnoli G, Cahillane C, Bustillo JC, Callister TA, Calloni E, Camp JB, Campbell WA, Canepa M, Cannon K, Cannon KC, Cao H, Cao J, Capocasa E, Carbognani F, Caride S, Carney MF, Carullo G, Diaz JC, Casentini C, Caudill S, Cavaglià M, Cavalier F, Cavalieri R, Cella G, Cerdá-Durán P, Cerretani G, Cesarini E, Chaibi O, Chakravarti K, Chamberlin SJ, Chan M, Chan ML, Chao S, Charlton P, Chase EA, Chassande-Mottin E, Chatterjee D, Chaturvedi M, Chatziioannou K, Cheeseboro BD, Chen CS, Chen HY, Chen KH, Chen X, Chen Y, Chen YR, Cheng HP, Cheong CK, Chia HY, Chincarini A, Chiummo A, Cho G, Cho HS, Cho M, Christensen N, Chu HY, Chu Q, Chu YK, Chua S, Chung KW, Chung S, Ciani G, Ciobanu AA, Ciolfi R, Cipriano F, Cirone A, Clara F, Clark JA, Clearwater P, Cleva F, Cocchieri C, Coccia E, Cohadon PF, Cohen D, Colgan R, Colleoni M, Collette CG, Collins C, Cominsky LR, Constancio M Jr, Conti L, Cooper SJ, Corban P, Corbitt TR, Cordero-Carrión I, Corley KR, Cornish N, Corsi A, Cortese S, Costa CA, Cotesta R, Coughlin MW, Coughlin SB, Coulon JP, Countryman ST, Couvares P, Covas PB, Cowan EE, Coward DM, Cowart MJ, Coyne DC, Coyne R, Creighton JDE, Creighton TD, Cripe J, Croquette M, Crowder SG, Cullen TJ, Cumming A, Cunningham L, Cuoco E, Canton TD, Dálya G, Danilishin SL, D'Antonio S, Danzmann K, Dasgupta A, Da Silva Costa CF, Datrier LEH, Dattilo V, Dave I, Davier M, Davis D, Daw EJ, DeBra D, Deenadayalan M, Degallaix J, De Laurentis M, Deléglise S, Pozzo WD, DeMarchi LM, Demos N, Dent T, De Pietri R, Derby J, De Rosa R, De Rossi C, DeSalvo R, de Varona O, Dhurandhar S, Díaz MC, Dietrich T, Fiore LD, Giovanni MD, Girolamo TD, Lieto AD, Ding B, Pace SD, Palma ID, Renzo FD, Dmitriev A, Doctor Z, Doi K, Donovan F, Dooley KL, Doravari S, Dorrington I, Downes TP, Drago M, Driggers JC, Du Z, Ducoin JG, Dupej P, Dwyer SE, Easter PJ, Edo TB, Edwards MC, Effler A, Eguchi S, Ehrens P, Eichholz J, Eikenberry SS, Eisenmann M, Eisenstein RA, Enomoto Y, Essick RC, Estelles H, Estevez D, Etienne ZB, Etzel T, Evans M, Evans TM, Fafone V, Fair H, Fairhurst S, Fan X, Farinon S, Farr B, Farr WM, Fauchon-Jones EJ, Favata M, Fays M, Fazio M, Fee C, Feicht J, Fejer MM, Feng F, Fernandez-Galiana A, Ferrante I, Ferreira EC, Ferreira TA, Ferrini F, Fidecaro F, Fiori I, Fiorucci D, Fishbach M, Fisher RP, Fishner JM, Fitz-Axen M, Flaminio R, Fletcher M, Flynn E, Fong H, Font JA, Forsyth PWF, Fournier JD, Frasca S, Frasconi F, Frei Z, Freise A, Frey R, Frey V, Fritschel P, Frolov VV, Fujii Y, Fukunaga M, Fukushima M, Fulda P, Fyffe M, Gabbard HA, Gadre BU, Gaebel SM, Gair JR, Gammaitoni L, Ganija MR, Gaonkar SG, Garcia A, García-Quirós C, Garufi F, Gateley B, Gaudio S, Gaur G, Gayathri V, Ge GG, Gemme G, Genin E, Gennai A, George D, George J, Gergely L, Germain V, Ghonge S, Ghosh A, Ghosh A, Ghosh S, Giacomazzo B, Giaime JA, Giardina KD, Giazotto A, Gill K, Giordano G, Glover L, Godwin P, Goetz E, Goetz R, Goncharov B, González G, Castro JMG, Gopakumar A, Gorodetsky ML, Gossan SE, Gosselin M, Gouaty R, Grado A, Graef C, Granata M, Grant A, Gras S, Grassia P, Gray C, Gray R, Greco G, Green AC, Green R, Gretarsson EM, Groot P, Grote H, Grunewald S, Gruning P, Guidi GM, Gulati HK, Guo Y, Gupta A, Gupta MK, Gustafson EK, Gustafson R, Haegel L, Hagiwara A, Haino S, Halim O, Hall BR, Hall ED, Hamilton EZ, Hammond G, Haney M, Hanke MM, Hanks J, Hanna C, Hannam MD, Hannuksela OA, Hanson J, Hardwick T, Haris K, Harms J, Harry GM, Harry IW, Hasegawa K, Haster CJ, Haughian K, Hayakawa H, Hayama K, Hayes FJ, Healy J, Heidmann A, Heintze MC, Heitmann H, Hello P, Hemming G, Hendry M, Heng IS, Hennig J, Heptonstall AW, Heurs M, Hild S, Himemoto Y, Hinderer T, Hiranuma Y, Hirata N, Hirose E, Hoak D, Hochheim S, Hofman D, Holgado AM, Holland NA, Holt K, Holz DE, Hong Z, Hopkins P, Horst C, Hough J, Howell EJ, Hoy CG, Hreibi A, Hsieh BH, Huang GZ, Huang PW, Huang YJ, Huerta EA, Huet D, Hughey B, Hulko M, Husa S, Huttner SH, Huynh-Dinh T, Idzkowski B, Iess A, Ikenoue B, Imam S, Inayoshi K, Ingram C, Inoue Y, Inta R, Intini G, Ioka K, Irwin B, Isa HN, Isac JM, Isi M, Itoh Y, Iyer BR, Izumi K, Jacqmin T, Jadhav SJ, Jani K, Janthalur NN, Jaranowski P, Jenkins AC, Jiang J, Johnson DS, Jones AW, Jones DI, Jones R, Jonker RJG, Ju L, Jung K, Jung P, Junker J, Kajita T, Kalaghatgi CV, Kalogera V, Kamai B, Kamiizumi M, Kanda N, Kandhasamy S, Kang GW, Kanner JB, Kapadia SJ, Karki S, Karvinen KS, Kashyap R, Kasprzack M, Katsanevas S, Katsavounidis E, Katzman W, Kaufer S, Kawabe K, Kawaguchi K, Kawai N, Kawasaki T, Keerthana NV, Kéfélian F, Keitel D, Kennedy R, Key JS, Khalili FY, Khan H, Khan I, Khan S, Khan Z, Khazanov EA, Khursheed M, Kijbunchoo N, Kim C, Kim C, Kim JC, Kim J, Kim K, Kim W, Kim WS, Kim YM, Kimball C, Kimura N, King EJ, King PJ, Kinley-Hanlon M, Kirchhoff R, Kissel JS, Kita N, Kitazawa H, Kleybolte L, Klika JH, Klimenko S, Knowles TD, Knyazev E, Koch P, Koehlenbeck SM, Koekoek G, Kojima Y, Kokeyama K, Koley S, Komori K, Kondrashov V, Kong AKH, Kontos A, Koper N, Korobko M, Korth WZ, Kotake K, Kowalska I, Kozak DB, Kozakai C, Kozu R, Kringel V, Krishnendu N, Królak A, Kuehn G, Kumar A, Kumar P, Kumar R, Kumar R, Kumar S, Kume J, Kuo CM, Kuo HS, Kuo L, Kuroyanagi S, Kusayanagi K, Kutynia A, Kwak K, Kwang S, Lackey BD, Lai KH, Lam TL, Landry M, Lane BB, Lang RN, Lange J, Lantz B, Lanza RK, Lartaux-Vollard A, Lasky PD, Laxen M, Lazzarini A, Lazzaro C, Leaci P, Leavey S, Lecoeuche YK, Lee CH, Lee HK, Lee HM, Lee HW, Lee J, Lee K, Lee RK, Lehmann J, Lenon A, Leonardi M, Leroy N, Letendre N, Levin Y, Li J, Li KJL, Li TGF, Li X, Lin CY, Lin F, Lin FL, Lin LCC, Linde F, Linker SD, Littenberg TB, Liu GC, Liu J, Liu X, Lo RKL, Lockerbie NA, London LT, Longo A, Lorenzini M, Loriette V, Lormand M, Losurdo G, Lough JD, Lousto CO, Lovelace G, Lower ME, Lück H, Lumaca D, Lundgren AP, Luo LW, Lynch R, Ma Y, Macas R, Macfoy S, MacInnis M, Macleod DM, Macquet A, Magaña-Sandoval F, Zertuche LM, Magee RM, Majorana E, Maksimovic I, Malik A, Man N, Mandic V, Mangano V, Mansell GL, Manske M, Mantovani M, Marchesoni F, Marchio M, Marion F, Márka S, Márka Z, Markakis C, Markosyan AS, Markowitz A, Maros E, Marquina A, Marsat S, Martelli F, Martin IW, Martin RM, Martynov DV, Mason K, Massera E, Masserot A, Massinger TJ, Masso-Reid M, Mastrogiovanni S, Matas A, Matichard F, Matone L, Mavalvala N, Mazumder N, McCann JJ, McCarthy R, McClelland DE, McCormick S, McCuller L, McGuire SC, McIver J, McManus DJ, McRae T, McWilliams ST, Meacher D, Meadors GD, Mehmet M, Mehta AK, Meidam J, Melatos A, Mendell G, Mercer RA, Mereni L, Merilh EL, Merzougui M, Meshkov S, Messenger C, Messick C, Metzdorff R, Meyers PM, Miao H, Michel C, Michimura Y, Middleton H, Mikhailov EE, Milano L, Miller AL, Miller A, Millhouse M, Mills JC, Milovich-Goff MC, Minazzoli O, Minenkov Y, Mio N, Mishkin A, Mishra C, Mistry T, Mitra S, Mitrofanov VP, Mitselmakher G, Mittleman R, Miyakawa O, Miyamoto A, Miyazaki Y, Miyo K, Miyoki S, Mo G, Moffa D, Mogushi K, Mohapatra SRP, Montani M, Moore CJ, Moraru D, Moreno G, Morisaki S, Moriwaki Y, Mours B, Mow-Lowry CM, Mukherjee A, Mukherjee D, Mukherjee S, Mukund N, Mullavey A, Munch J, Muñiz EA, Muratore M, Murray PG, Nagano K, Nagano S, Nagar A, Nakamura K, Nakano H, Nakano M, Nakashima R, Nardecchia I, Narikawa T, Naticchioni L, Nayak RK, Negishi R, Neilson J, Nelemans G, Nelson TJN, Nery M, Neunzert A, Ng KY, Ng S, Nguyen P, Ni WT, Nichols D, Nishizawa A, Nissanke S, Nocera F, North C, Nuttall LK, Obergaulinger M, Oberling J, O'Brien BD, Obuchi Y, O'Dea GD, Ogaki W, Ogin GH, Oh JJ, Oh SH, Ohashi M, Ohishi N, Ohkawa M, Ohme F, Ohta H, Okada MA, Okutomi K, Oliver M, Oohara K, Ooi CP, Oppermann P, Oram RJ, O'Reilly B, Ormiston RG, Ortega LF, O'Shaughnessy R, Oshino S, Ossokine S, Ottaway DJ, Overmier H, Owen BJ, Pace AE, Pagano G, Page MA, Pai A, Pai SA, Palamos JR, Palashov O, Palomba C, Pal-Singh A, Pan HW, Pan KC, Pang B, Pang HF, Pang PTH, Pankow C, Pannarale F, Pant BC, Paoletti F, Paoli A, Papa MA, Parida A, Park J, Parker W, Pascucci D, Pasqualetti A, Passaquieti R, Passuello D, Patil M, Patricelli B, Pearlstone BL, Pedersen C, Pedraza M, Pedurand R, Pele A, Arellano FEP, Penn S, Perez CJ, Perreca A, Pfeiffer HP, Phelps M, Phukon KS, Piccinni OJ, Pichot M, Piergiovanni F, Pillant G, Pinard L, Pinto I, Pirello M, Pitkin M, Poggiani R, Pong DYT, Ponrathnam S, Popolizio P, Porter EK, Powell J, Prajapati AK, Prasad J, Prasai K, Prasanna R, Pratten G, Prestegard T, Privitera S, Prodi GA, Prokhorov LG, Puncken O, Punturo M, Puppo P, Pürrer M, Qi H, Quetschke V, Quinonez PJ, Quintero EA, Quitzow-James R, Raab FJ, Radkins H, Radulescu N, Raffai P, Raja S, Rajan C, Rajbhandari B, Rakhmanov M, Ramirez KE, Ramos-Buades A, Rana J, Rao K, Rapagnani P, Raymond V, Razzano M, Read J, Regimbau T, Rei L, Reid S, Reitze DH, Ren W, Ricci F, Richardson CJ, Richardson JW, Ricker PM, Riles K, Rizzo M, Robertson NA, Robie R, Robinet F, Rocchi A, Rolland L, Rollins JG, Roma VJ, Romanelli M, Romano R, Romel CL, Romie JH, Rose K, Rosińska D, Rosofsky SG, Ross MP, Rowan S, Rüdiger A, Ruggi P, Rutins G, Ryan K, Sachdev S, Sadecki T, Sago N, Saito S, Saito Y, Sakai K, Sakai Y, Sakamoto H, Sakellariadou M, Sakuno Y, Salconi L, Saleem M, Samajdar A, Sammut L, Sanchez EJ, Sanchez LE, Sanchis-Gual N, Sandberg V, Sanders JR, Santiago KA, Sarin N, Sassolas B, Sathyaprakash BS, Sato S, Sato T, Sauter O, Savage RL, Sawada T, Schale P, Scheel M, Scheuer J, Schmidt P, Schnabel R, Schofield RMS, Schönbeck A, Schreiber E, Schulte BW, Schutz BF, Schwalbe SG, Scott J, Scott SM, Seidel E, Sekiguchi T, Sekiguchi Y, Sellers D, Sengupta AS, Sennett N, Sentenac D, Sequino V, Sergeev A, Setyawati Y, Shaddock DA, Shaffer T, Shahriar MS, Shaner MB, Shao L, Sharma P, Shawhan P, Shen H, Shibagaki S, Shimizu R, Shimoda T, Shimode K, Shink R, Shinkai H, Shishido T, Shoda A, Shoemaker DH, Shoemaker DM, ShyamSundar S, Siellez K, Sieniawska M, Sigg D, Silva AD, Singer LP, Singh N, Singhal A, Sintes AM, Sitmukhambetov S, Skliris V, Slagmolen BJJ, Slaven-Blair TJ, Smith JR, Smith RJE, Somala S, Somiya K, Son EJ, Sorazu B, Sorrentino F, Sotani H, Souradeep T, Sowell E, Spencer AP, Srivastava AK, Srivastava V, Staats K, Stachie C, Standke M, Steer DA, Steinke M, Steinlechner J, Steinlechner S, Steinmeyer D, Stevenson SP, Stocks D, Stone R, Stops DJ, Strain KA, Stratta G, Strigin SE, Strunk A, Sturani R, Stuver AL, Sudhir V, Sugimoto R, Summerscales TZ, Sun L, Sunil S, Suresh J, Sutton PJ, Suzuki T, Suzuki T, Swinkels BL, Szczepańczyk MJ, Tacca M, Tagoshi H, Tait SC, Takahashi H, Takahashi R, Takamori A, Takano S, Takeda H, Takeda M, Talbot C, Talukder D, Tanaka H, Tanaka K, Tanaka K, Tanaka T, Tanaka T, Tanioka S, Tanner DB, Tápai M, Martin ENTS, Taracchini A, Tasson JD, Taylor R, Telada S, Thies F, Thomas M, Thomas P, Thondapu SR, Thorne KA, Thrane E, Tiwari S, Tiwari S, Tiwari V, Toland K, Tomaru T, Tomigami Y, Tomura T, Tonelli M, Tornasi Z, Torres-Forné A, Torrie CI, Töyrä D, Travasso F, Traylor G, Tringali MC, Trovato A, Trozzo L, Trudeau R, Tsang KW, Tsang TTL, Tse M, Tso R, Tsubono K, Tsuchida S, Tsukada L, Tsuna D, Tsuzuki T, Tuyenbayev D, Uchikata N, Uchiyama T, Ueda A, Uehara T, Ueno K, Ueshima G, Ugolini D, Unnikrishnan CS, Uraguchi F, Urban AL, Ushiba T, Usman SA, Vahlbruch H, Vajente G, Valdes G, Bakel NV, Beuzekom MV, Brand JFJVD, Broeck CVD, Vander-Hyde DC, Schaaf LV, Heijningen JVV, Putten MHPMV, Veggel AAV, Vardaro M, Varma V, Vass S, Vasúth M, Vecchio A, Vedovato G, Veitch J, Veitch PJ, Venkateswara K, Venugopalan G, Verkindt D, Vetrano F, Viceré A, Viets AD, Vine DJ, Vinet JY, Vitale S, Vivanco FH, Vo T, Vocca H, Vorvick C, Vyatchanin SP, Wade AR, Wade LE, Wade M, Walet R, Walker M, Wallace L, Walsh S, Wang G, Wang H, Wang J, Wang JZ, Wang WH, Wang YF, Ward RL, Warden ZA, Warner J, Was M, Watchi J, Weaver B, Wei LW, Weinert M, Weinstein AJ, Weiss R, Wellmann F, Wen L, Wessel EK, Weßels P, Westhouse JW, Wette K, Whelan JT, Whiting BF, Whittle C, Wilken DM, Williams D, Williamson AR, Willis JL, Willke B, Wimmer MH, Winkler W, Wipf CC, Wittel H, Woan G, Woehler J, Wofford JK, Worden J, Wright JL, Wu CM, Wu DS, Wu HC, Wu SR, Wysocki DM, Xiao L, Xu WR, Yamada T, Yamamoto H, Yamamoto K, Yamamoto K, Yamamoto T, Yancey CC, Yang L, Yap MJ, Yazback M, Yeeles DW, Yokogawa K, Yokoyama J, Yokozawa T, Yoshioka T, Yu H, Yu H, Yuen SHR, Yuzurihara H, Yvert M, Zadrożny AK, Zanolin M, Zeidler S, Zelenova T, Zendri JP, Zevin M, Zhang J, Zhang L, Zhang T, Zhao C, Zhao Y, Zhou M, Zhou Z, Zhu XJ, Zhu ZH, Zimmerman AB, Zucker ME, and Zweizig J
- Abstract
We present our current best estimate of the plausible observing scenarios for the Advanced LIGO, Advanced Virgo and KAGRA gravitational-wave detectors over the next several years, with the intention of providing information to facilitate planning for multi-messenger astronomy with gravitational waves. We estimate the sensitivity of the network to transient gravitational-wave signals for the third (O3), fourth (O4) and fifth observing (O5) runs, including the planned upgrades of the Advanced LIGO and Advanced Virgo detectors. We study the capability of the network to determine the sky location of the source for gravitational-wave signals from the inspiral of binary systems of compact objects, that is binary neutron star, neutron star-black hole, and binary black hole systems. The ability to localize the sources is given as a sky-area probability, luminosity distance, and comoving volume. The median sky localization area (90% credible region) is expected to be a few hundreds of square degrees for all types of binary systems during O3 with the Advanced LIGO and Virgo (HLV) network. The median sky localization area will improve to a few tens of square degrees during O4 with the Advanced LIGO, Virgo, and KAGRA (HLVK) network. During O3, the median localization volume (90% credible region) is expected to be on the order of 10 5 , 10 6 , 10 7 Mpc 3 for binary neutron star, neutron star-black hole, and binary black hole systems, respectively. The localization volume in O4 is expected to be about a factor two smaller than in O3. We predict a detection count of 1 - 1 + 12 ( 10 - 10 + 52 ) for binary neutron star mergers, of 0 - 0 + 19 ( 1 - 1 + 91 ) for neutron star-black hole mergers, and 17 - 11 + 22 ( 79 - 44 + 89 ) for binary black hole mergers in a one-calendar-year observing run of the HLV network during O3 (HLVK network during O4). We evaluate sensitivity and localization expectations for unmodeled signal searches, including the search for intermediate mass black hole binary mergers., (© The Author(s) 2020.)
- Published
- 2020
- Full Text
- View/download PDF
18. Renal hemosiderosis secondary to intravascular hemolysis after mitral valve repair: A case report.
- Author
-
Lee IH, Kang GW, Kim CY, Lee SJ, Kim MK, and Ahn DJ
- Subjects
- Female, Hemosiderosis etiology, Hemosiderosis pathology, Humans, Kidney Diseases etiology, Kidney Diseases pathology, Middle Aged, Mitral Valve Insufficiency surgery, Postoperative Complications pathology, Heart Valve Prosthesis Implantation, Hemolysis, Hemosiderosis diagnosis, Kidney Diseases diagnosis, Postoperative Complications diagnosis
- Abstract
Rationale: Renal hemosiderosis is a disease in which hemosiderin deposits in the renal cortex as a form of iron overload. However, cases of renal hemosiderosis due to intravascular hemolysis following mitral valve repair have been rarely reported., Patient Concerns: We present the case of a 62-year-old woman who developed asymptomatic urinary abnormalities including microscopic hematuria and proteinuria due to renal hemosiderosis following a mitral valve repair surgery performed two years earlier., Diagnoses: A percutaneous renal biopsy showed no specific glomerular abnormality, tubular atrophy, or interstitial fibrosis but extensive deposition of hemosiderin in the proximal tubule. The patient was diagnosed with renal hemosiderosis and chronic intravascular hemolysis following mitral valve repair., Interventions: Our patient refused a mitral valve repeat surgery and hence was treated with oral iron preparations, N-acetylcysteine, and a β-receptor blocker., Outcomes: Moderate mitral regurgitation with the regurgitant blood striking against the annuloplasty ring was confirmed on follow-up echocardiography. After the 24-month follow-up period, hemolytic anemia persisted, but there was no significant decline of renal function., Lessons: For cases of chronic intravascular hemolysis accompanied with asymptomatic urinary abnormalities, a renal biopsy is required to exclude underlying kidney pathology and predict potential renal insufficiency.
- Published
- 2020
- Full Text
- View/download PDF
19. Efficacy and safety of CKD-11101 (darbepoetin-alfa proposed biosimilar) compared with NESP in anaemic chronic kidney disease patients not on dialysis.
- Author
-
Lee JH, Ha Chung B, Joo KW, Shin SK, Kim YL, Na KY, Do JY, Park SK, Shin BC, Lee JS, Kim YW, Kim SW, Lee KW, Kang GW, An WS, Shin GT, Han S, and Yang CW
- Subjects
- Adult, Aged, Biosimilar Pharmaceuticals adverse effects, Darbepoetin alfa adverse effects, Double-Blind Method, Female, Humans, Male, Middle Aged, Renal Insufficiency, Chronic therapy, Anemia drug therapy, Biosimilar Pharmaceuticals therapeutic use, Darbepoetin alfa therapeutic use, Renal Dialysis adverse effects, Renal Insufficiency, Chronic complications
- Abstract
Objective: To evaluate the efficacy and safety of CKD-11101 (biosimilar darbepoetin-alfa, Chong Kun Dang Pharm.) compared with NESP® in treatment of anaemia in patients with chronic kidney disease not on dialysis., Clinical Trial Registration: NCT03431623., Method: In this multi-centre, randomized, double-blind study, patients were treated with CKD-11101 and NESP. The efficacy evaluation period (EEP) was 24 weeks, during which patients were treated every 2 weeks. All patients who completed the EEP were treated with CKD-11101 every 2 weeks for the first 4 weeks and every 4 weeks for the safety evaluation period (SEP), which was from 24 weeks to 52 weeks. The primary efficacy endpoint was the change in mean haemoglobin (Hb) level from baseline to end of EEP and mean dose needed to achieve the target Hb., Results: The mean Hb level was increased in both groups during the EEP (both p < 0.001). The difference in mean Hb level change between the two groups was 0.01 g/dL (95% CI = -0.213-0.242), indicating that CKD-11101 was equivalent to NESP. The difference in mean administration dose between groups was -1.40 mcg (95% CI = -6.859-4.059) included in the equivalent range. The incidence of AEs and ADRs was not different between the two groups, and the frequency of ADRs was favourable in both groups (1.2% in CKD-11101 vs 7.7% in the NESP to CKD-11101 conversion group)., Conclusion: CKD-11101 has an equivalent therapeutic effect as NESP in chronic kidney disease patients with renal anaemia. CKD-11101 can be safely used for long-term treatment and in patients converted from NESP.
- Published
- 2019
- Full Text
- View/download PDF
20. A case report on the acute and late complications associated with carbon monoxide poisoning: Acute kidney injury, rhabdomyolysis, and delayed leukoencephalopathy.
- Author
-
Kim SG, Woo J, and Kang GW
- Subjects
- Acute Kidney Injury physiopathology, Acute Kidney Injury therapy, Adult, Brain diagnostic imaging, Carbon Monoxide Poisoning diagnostic imaging, Carbon Monoxide Poisoning physiopathology, Carbon Monoxide Poisoning therapy, Female, Humans, Leukoencephalopathies diagnostic imaging, Leukoencephalopathies physiopathology, Leukoencephalopathies therapy, Rhabdomyolysis physiopathology, Rhabdomyolysis therapy, Suicide, Attempted, Acute Kidney Injury etiology, Carbon Monoxide Poisoning complications, Leukoencephalopathies etiology, Rhabdomyolysis etiology
- Abstract
Rationale: Acute kidney injury (AKI), rhabdomyolysis, and delayed leukoencephalopathy after carbon monoxide (CO) poisoning are very rare. We report a case presenting with AKI, rhabdomyolysis, and delayed leukoencephalopathy after CO poisoning., Patient Concerns: The patient was admitted to our emergency department due to loss of consciousness after CO exposure during a suicide attempt., Diagnoses: Laboratory findings revealed elevated carboxyhemoglobin, serum creatinine, and serum muscle enzyme levels. Initially, this patient was diagnosed with AKI and rhabdomyolysis due to CO poisoning. A month after the CO poisoning, she showed neuropsychiatric symptoms. Brain magnetic resonance imaging showed white-matter hyperintensity on the T2 flair image. Therefore, she was diagnosed with delayed leukoencephalopathy after CO poisoning., Interventions: At the same time as diagnosis of AKI and rhabdomyolysis, the normobaric oxygen and hydration therapies were performed. A month later, rehabilitation was started due to delayed leukoencephalopathy., Outcomes: Her renal function and muscle enzyme levels were completely restored with alert mental status. She could walk with the aid of a walker at last visit., Lessons: This case shows that we should consider about rare acute and late complications such as AKI, rhabdomyolysis, and delayed leukoencephalopathy after CO poisoning.
- Published
- 2019
- Full Text
- View/download PDF
21. Cryptopimpla (Hymenoptera, Ichneumonidae, Banchinae) of South Korea, with description of two new species.
- Author
-
Kang GW, Kolarov J, and Lee JW
- Abstract
The genus Cryptopimpla Taschenberg is recorded for the first time in South Korea. Four species are recognized; among these, two species, C.aspeculosus Kang & Lee, sp. n. and C.pentagonalis Kang & Lee, sp. n. , are described as new to science. For the other two species, C.brevigena Kuslitzkii and C.carinifacialis Sheng, the males were hitherto unknown and are described here. An illustrated identification key is provided for the species of Cryptopimpla known from South Korea.
- Published
- 2019
- Full Text
- View/download PDF
22. A new species of Monoblastus Hartig, 1837 (Hymenoptera: Ichneumonidae: Tryphoninae) from South Korea.
- Author
-
Kasparyan DR, Choi JK, Kang GW, and Lee JW
- Subjects
- Animals, Islands, Republic of Korea, Russia, Animal Distribution, Hymenoptera
- Abstract
A new ichneumonid species, Monoblastus koreensis sp. nov. is described from South Korea. New data on the taxonomy and distribution of M. clauseni (Uchida), M. erythrurus Townes et al. and M. nigriventus Lee Cha are given. The taxonomic position of M. nigriventus and its similarity to M. ermolenkoi Kasparyan from Russian Kuril Islands is discussed. All these species are keyed and illustrated. Erromenus alpinator Aubert sensu Lee Cha (= Monoblastus koreensis sp. nov.) is excluded from the fauna of South Korea.
- Published
- 2018
- Full Text
- View/download PDF
23. The Quality of Life of Hemodialysis Patients Is Affected Not Only by Medical but also Psychosocial Factors: a Canonical Correlation Study.
- Author
-
Kim K, Kang GW, and Woo J
- Subjects
- Adaptation, Psychological, Adult, Aged, Anxiety pathology, Depression pathology, Female, Humans, Male, Middle Aged, Renal Dialysis, Social Support, Surveys and Questionnaires, Kidney Failure, Chronic psychology, Quality of Life
- Abstract
Background: The quality of life (QoL) of patients with end-stage renal disease (ESRD) is very poor, plausibly due to both psychosocial and medical factors. This study aimed to determine the relationship among psychosocial factors, medical factors, and QoL in patients with ESRD undergoing hemodialysis (HD)., Methods: In total, 55 male and 47 female patients were evaluated (mean age, 57.1 ± 12.0 years). The QoL was evaluated using the Korean version of World Health Organization Quality of Life Scale-Abbreviated Version. The psychosocial factors were evaluated using the Hospital Anxiety and Depression Scale, Multidimensional Scale of Perceived Social Support, Montreal Cognitive Assessment, Pittsburgh Sleep Quality Index, and Zarit Burden Interview. The medical factors were assessed using laboratory examinations. Correlation and canonical correlation analyses were performed to investigate the association patterns., Results: The QoL was significantly correlated with the psychosocial factors, and to a lesser extent with the medical factors. The medical and psychosocial factors were also correlated. The canonical correlation analysis indicated a correlation between QoL and psychosocial factors (1st canonical correlation = 0.696, P < 0.001; 2nd canonical correlation = 0.421, P = 0.191), but not medical factors (1st canonical correlation = 0.478, P = 0.475; 2nd canonical correlation = 0.419, P = 0.751). The medical and psychosocial factors were also correlated (1st canonical correlation = 0.689, P < 0.001; 2nd canonical correlation = 0.603, P = 0.009)., Conclusion: Psychosocial factors influence QoL in patients with ESRD, and should thus be carefully considered when caring for these patients in clinical practice., Competing Interests: The authors have no potential conflicts of interest to disclose., (© 2018 The Korean Academy of Medical Sciences.)
- Published
- 2018
- Full Text
- View/download PDF
24. Incidence, prevalence, mortality and causes of death in systemic sclerosis in Korea: a nationwide population-based study.
- Author
-
Kang GW, Jung KH, Lee YS, Kim HJ, Yoon DY, Lee SH, Hann HJ, Kim KH, Han S, Kim Y, Kim DS, and Ahn HS
- Subjects
- Adolescent, Adult, Aged, Aged, 80 and over, Cause of Death, Child, Child, Preschool, Female, Humans, Incidence, Infant, Infant, Newborn, Male, Middle Aged, Prevalence, Republic of Korea epidemiology, Sex Distribution, Young Adult, Scleroderma, Systemic mortality
- Published
- 2018
- Full Text
- View/download PDF
25. Diabetes mellitus as a risk factor for glaucoma outcome in Korea.
- Author
-
Kim SW and Kang GW
- Subjects
- Diabetes Mellitus, Diabetes Mellitus, Type 2, Glaucoma, Open-Angle, Humans, Republic of Korea, Risk Factors, Glaucoma, Ocular Hypertension
- Published
- 2017
- Full Text
- View/download PDF
26. ESTIMATION OF THE CUMULATIVE EXPOSURE FREQUENCY AND CUMULATIVE EFFECTIVE DOSE OF DIAGNOSTIC MEDICAL RADIATION IN THE KOREAN POPULATION FROM 2002 TO 2010.
- Author
-
Gil JW, Kim SY, Park WY, Kim WD, Lee YS, Kang GW, Shin DW, Park CY, and Park JH
- Subjects
- Adolescent, Adult, Aged, Aged, 80 and over, Child, Female, Humans, Male, Middle Aged, Republic of Korea, Risk Factors, Diagnostic Imaging, Radiation Dosage, Radiation Monitoring methods
- Abstract
Along with increase in the frequency and exposure dose from the diagnostic medical radiation procedures, the public's interest in radiation exposure has also been growing. In this study, in order to estimate the Cumulative Exposure Frequency and the cumulative effective dose of diagnostic medical radiation in the Korean population, we included 680 diagnostic medical radiation procedure codes of the Health Insurance Review & Assessment Service's health insurance medical expenses data and adopted the effective dose data from the 2008 report of the United Nations Scientific Committee on the Effects of Atomic Radiation. We combined the data of one million individuals in the national sample cohort database (2002-10) of the National Health Insurance Service. The results revealed that 93.2% (917 972) of the subjects were exposed to diagnostic medical radiation at least once in the past nine years, and the Cumulative Exposure Frequency was 17 286.4 per 1000 individuals with a cumulative effective dose of 5.7 (±17.8) mSv per person. Additionally, 93.1% (854 480) of the subjects had a cumulative effective dose less than 20 mSv, and 0.7% (6139) had a dose that exceeded 100 mSv (extreme), showing that the dosage level was mostly low. However, the number of individuals whose exposure exceeded 100 mSv/y increased 28-fold, from 18 in 2002 to 500 in 2010. In addition, the size of increase also grew each year, suggesting that cancer occurrence due to diagnostic medical radiation may have also increased. In order determine the causal relationship between cancer occurrence and diagnostic medical radiation and setup a guideline for exposure, it is necessary to monitor individual cumulative exposure doses nation-wide and follow up on heavily exposed individuals for an extended period of time., (© The Author 2017. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oup.com.)
- Published
- 2017
- Full Text
- View/download PDF
27. Hypersensitivity pneumonitis associated with azathioprine therapy in a patient with granulomatosis with polyangiitis.
- Author
-
Lee IH, Kang GW, and Kim KC
- Subjects
- Adult, Alveolitis, Extrinsic Allergic diagnosis, Alveolitis, Extrinsic Allergic immunology, Biopsy, Bronchoscopy, Drug Hypersensitivity diagnosis, Drug Hypersensitivity immunology, Granulomatosis with Polyangiitis diagnosis, Humans, Male, Predictive Value of Tests, Time Factors, Tomography, X-Ray Computed, Treatment Outcome, Alveolitis, Extrinsic Allergic chemically induced, Azathioprine adverse effects, Drug Hypersensitivity etiology, Granulomatosis with Polyangiitis drug therapy, Immunosuppressive Agents administration & dosage
- Abstract
Granulomatosis with polyangiitis (GPA), an autoimmune disease characterized by inflammatory granulomas and necrotizing small-vessel vasculitis, primarily affects the respiratory tract and kidneys. Azathioprine (AZA) is a purine analog that is commonly used for maintaining GPA remission after induction therapy with cyclophosphamide. While the dose-dependent side effects of AZA are common and well known, hypersensitivity reactions such as pulmonary toxicity are rare. Here, we describe a case involving a 38-year-old man with GPA-associated pauci-immune crescentic glomerulonephritis who developed subacute hypersensitivity pneumonitis (HP) during AZA maintenance therapy. Five months after the initiation of AZA administration (100 mg/day), the patient was admitted with a 7-day history of cough, dyspnea, and fever. High-resolution computed tomography of the chest showed ill-defined centrilobular nodules and diffuse ground-glass opacities in both lung fields. Bronchoscopy with bronchoalveolar lavage was negative for infectious etiologies. A transbronchial lung biopsy specimen revealed poorly formed non-necrotizing granulomas. A chest radiograph obtained at 2 weeks after discontinuation of AZA showed normal findings. The findings from this case suggest that AZA-induced HP should be considered as a differential diagnosis when a patient with GPA exhibits fresh pulmonary lesions accompanied by respiratory symptoms during AZA therapy.
- Published
- 2016
- Full Text
- View/download PDF
28. The General Public's Awareness of Early Symptoms of and Emergency Responses to Acute Myocardial Infarction and Related Factors in South Korea: A National Public Telephone Survey.
- Author
-
Kim HS, Lee H, Kim K, Park HK, Park KS, Kang GW, Shin HY, Kim RB, Oh GJ, Seo JH, and Lee YH
- Subjects
- Adult, Age Factors, Aged, Educational Status, Female, Humans, Male, Middle Aged, Republic of Korea, Surveys and Questionnaires, Telephone, Young Adult, Early Diagnosis, Emergency Treatment, Health Knowledge, Attitudes, Practice, Myocardial Infarction diagnosis, Myocardial Infarction therapy
- Abstract
Background: Prompt treatment affects prognosis and survival after acute myocardial infarction (AMI) onset. This study evaluated the awareness of early symptoms of AMI and knowledge of appropriate responses on symptom occurrence, along with related factors., Methods: Participants' knowledge of the early symptoms of and responses to AMI onset were investigated using a random digit dialing survey. We included 9600 residents of 16 metropolitan cities and provinces in Korea., Results: The proportions of respondents who were aware of early symptoms of AMI ranged from 32.9% (arm or shoulder pain) to 79.1% (chest pain and discomfort). Of the respondents, 67.0% would call an ambulance if someone showed signs of AMI, 88.7% knew ≥1 symptom, 10.9% knew all five symptoms, and 3.1% had excellent knowledge (correct identification of all five AMI symptoms, not answering "Yes" to the trap question, and correctly identifying calling an ambulance as the appropriate response when someone is exhibiting AMI symptoms). The odds ratio (OR) for having excellent knowledge was significantly higher for those who graduated college or higher (OR 3.42; 95% confidence interval [CI], 1.09-10.76) than for those with less than a primary school education, as well as for subjects with AMI advertisement exposure (OR 1.49; 95% CI, 1.10-2.02) and with knowledge of AMI (OR 1.63; 95% CI, 1.16-2.27). The 60- to 79-year-old group had significantly lower OR for excellent knowledge than the 20- to 39-year-old group (OR 0.53; 95% CI, 0.28-0.99)., Conclusions: Awareness of AMI symptoms and the appropriate action to take after symptom onset in South Korea was poor. Therefore, educational and promotional strategies to increase the overall awareness in the general public, especially in the elderly and those with low education levels, are needed.
- Published
- 2016
- Full Text
- View/download PDF
29. One-Year Follow-up of the Changes in Renal Function After Liver Transplantation in Patients Without Chronic Kidney Disease.
- Author
-
Kang GW, Lee IH, Ahn KS, Kim JD, Kwak SG, and Choi DL
- Subjects
- Adult, Age Factors, Female, Follow-Up Studies, Humans, Kidney Function Tests, Logistic Models, Male, Middle Aged, Multivariate Analysis, Retrospective Studies, Risk Factors, Sex Factors, Calcineurin Inhibitors therapeutic use, Diabetes Mellitus epidemiology, Glomerular Filtration Rate, Graft Rejection prevention & control, Hepatitis C epidemiology, Hypertension epidemiology, Liver Diseases surgery, Liver Transplantation, Postoperative Complications epidemiology, Proteinuria epidemiology, Renal Insufficiency, Chronic epidemiology
- Abstract
Background: Impaired renal function is a strong risk factor for morbidity and mortality after liver transplantation (LT). There is clearly a progressive deterioration in renal function after LT. The greatest loss of renal function occurs within the 1st year after LT. Several factors, including calcineurin inhibitors, are associated with decreased renal function. The aims of the present study were to identify changes in renal function before and after LT and to determine the risk factors related to decreased renal function after LT., Methods: We reviewed medical records of 106 LT recipients without moderate to severe chronic kidney disease (estimated glomerular filtration rate [eGFR] ≥60 mL/min/1.73 m(2)). We investigated eGFR changes from before to 1 year after LT with the use of propensity score matching. Statistical significance of differences between clinical parameters and 1-year eGFR changes was assessed with the use of univariate and multivariate analyses., Results: Mean age was 49.5 ± 10.9 years, and 66% of the patients were male. Mean differences in 1-year eGFR and serum creatinine were -32.0 ± 29.2 mL/min/1.73 m(2) and 0.3 ± 0.3 mg/dL, respectively. Variables significantly associated with renal dysfunction 1 year after LT were old age, low pre-LT eGFR, low post-LT hemoglobin, and perioperative acute kidney injury. Multivariate analysis showed that pre-LT renal function was an independent risk factor for decreased renal function after LT. However, there was no significant correlation between 1-year eGFR change and serum tacrolimus level., Conclusions: Renal function significantly decreased the 1st year after LT, and baseline renal function was an independent risk factor for worsening renal function in LT recipients., (Copyright © 2016 Elsevier Inc. All rights reserved.)
- Published
- 2016
- Full Text
- View/download PDF
30. Ganciclovir and Foscarnet Therapy of Cytomegalovirus-Associated Meningoencephalitis in a Hemodialysis Patient With Liver Transplantation: Case Report.
- Author
-
Kang GW, Hong HL, Lee IH, Ahn KS, Kim JD, and Choi DL
- Subjects
- Cytomegalovirus genetics, Cytomegalovirus Infections diagnosis, Cytomegalovirus Infections etiology, Drug Therapy, Combination, Female, Humans, Kidney Failure, Chronic complications, Meningoencephalitis diagnosis, Meningoencephalitis etiology, Middle Aged, Polymerase Chain Reaction, Antiviral Agents therapeutic use, Cytomegalovirus Infections drug therapy, Foscarnet therapeutic use, Ganciclovir therapeutic use, Graft Rejection prevention & control, Immunosuppressive Agents adverse effects, Kidney Failure, Chronic therapy, Liver Transplantation, Meningoencephalitis drug therapy, Renal Dialysis
- Abstract
Cytomegalovirus (CMV) infection in patients with liver transplantation (LT) remains a highly prevalent complication with a significant increase in morbidity and mortality. However, CMV-associated meningoencephalitis is rarely diagnosed, and treatment is very difficult. The aim of the present report is to review the experience of successful treatment with combined ganciclovir and foscarnet of CMV-associated meningoencephalitis refractory to ganciclovir alone in a hemodialysis (HD) patient after LT. A 54-year-old woman with end-stage renal disease on HD developed a seizure with loss of consciousness. She had received a liver transplant 4 months before. Blood CMV polymerase chain reaction was positive, and cerebrospinal fluid (CSF) analysis was compatible with viral meningitis. Brain magnetic resonance imaging (MRI) showed extensive dural thickening with enhancement and a round ring-like enhancement in the left centrum semiovale. She was diagnosed with CMV-associated meningoencephalitis. At that time, ganciclovir was started intravenously. After that, there were no improvements in mental state, CSF analysis, or brain MRI. Intravenous foscarnet at reduced dose was added to ganciclovir therapy. With combined ganciclovir and foscarnet, there was a slight improvement in her mental state and brain MRI., (Copyright © 2016 Elsevier Inc. All rights reserved.)
- Published
- 2016
- Full Text
- View/download PDF
31. Cost-Utility Analysis of Screening Strategies for Diabetic Retinopathy in Korea.
- Author
-
Kim SW and Kang GW
- Subjects
- Adult, Aged, Aged, 80 and over, Diabetic Retinopathy economics, Diagnostic Techniques, Ophthalmological economics, Early Diagnosis, Female, Fluorescein Angiography economics, Health Care Costs, Humans, Male, Markov Chains, Mass Screening methods, Mass Screening statistics & numerical data, Middle Aged, Models, Economic, National Health Programs economics, Quality-Adjusted Life Years, Republic of Korea, Cost-Benefit Analysis, Diabetic Retinopathy diagnosis, Diabetic Retinopathy therapy, Mass Screening economics
- Abstract
This study involved a cost-utility analysis of early diagnosis and treatment of diabetic retinopathy depending on the screening strategy used. The four screening strategies evaluated were no screening, opportunistic examination, systematic fundus photography, and systematic examination by an ophthalmologists. Each strategy was evaluated in 10,000 adults aged 40 yr with newly diagnosed diabetes mellitus (hypothetical cohort). The cost of each strategy was estimated in the perspective of both payer and health care system. The utility was estimated using quality-adjusted life years (QALY). Incremental Cost Effectiveness Ratio (ICER) for the different screening strategies was analyzed. After exclusion of the weakly dominating opportunistic strategy, the ICER of systematic photography was 57,716,867 and that of systematic examination by ophthalmologists was 419,989,046 from the perspective of the healthcare system. According to the results, the systematic strategy is preferable to the opportunistic strategy from the perspective of both a payer and a healthcare system. Although systematic examination by ophthalmologists may have higher utility than systematic photography, it is associated with higher cost. The systematic photography is the best strategy in terms of cost-utility. However systematic examination by ophthalmologists can also be a suitable policy alternative, if the incremental cost is socially acceptable.
- Published
- 2015
- Full Text
- View/download PDF
32. Clinical and psychosocial factors predicting health-related quality of life in hemodialysis patients.
- Author
-
Kang GW, Lee IH, Ahn KS, Lee J, Ji Y, and Woo J
- Subjects
- Cross-Sectional Studies, Female, Humans, Male, Middle Aged, Surveys and Questionnaires, Kidney Failure, Chronic psychology, Quality of Life psychology, Renal Dialysis psychology
- Abstract
Many patients with end-stage renal disease have significant impairment in health-related quality of life (HRQoL). Most previous studies have focused on clinical factors; however, quality of life can also be affected by psychosocial factors. The aim of this study was to identify the possible predictors of HRQoL among clinical and psychosocial factors in hemodialysis (HD) patients. The study included 101 patients who were undergoing HD. Psychosocial factors were evaluated using the Hospital Anxiety and Depression Scale, Multidimensional Scale of Perceived Social Support, Montreal Cognitive Assessment, and Pittsburgh Sleep Quality Index. We also assessed laboratory and clinical factors, including albumin, Kt/V as a marker of dialysis adequacy, normalized protein catabolic rate, and duration of HD. The Euro Quality of Life Questionnaire 5-Dimensional Classification (EQ-5D) was used to evaluate HRQoL. The mean EQ-5D index score was 0.704 ± 0.199. The following variables showed a significant association with the EQ-5D index: age (P < 0.001), depression (P < 0.001), anxiety (P < 0.001), support from friends (P < 0.001), cognitive function (P < 0.001), duration of HD (P = 0.034), triglyceride (P = 0.031), total iron-binding capacity (P = 0.036), and phosphorus (P = 0.037). Multiple regression analysis showed that age (95% confidence interval [CI] -0.008 to -0.002), anxiety (95% CI -0.025 to -0.009), and support from friends (95% CI 0.004 to 0.018) were independent predictors of impaired HRQoL. This study explored determinants of impaired HRQoL in HD patients. We found that impaired HRQoL was independently associated with age, anxiety, and support from friends. We should consider psychosocial as well as clinical factors when evaluating ways to improve HRQoL in HD patients., (© 2015 International Society for Hemodialysis.)
- Published
- 2015
- Full Text
- View/download PDF
33. Two new species of Leptobatopsis Ashmead (Hymenoptera: Ichneumonidae: Banchinae) from South Korea and gynandromorphy in L. nigricapitis.
- Author
-
Choi JK, Kang GW, and Lee JW
- Subjects
- Animal Distribution, Animal Structures anatomy & histology, Animal Structures growth & development, Animals, Body Size, Female, Male, Organ Size, Republic of Korea, Wasps anatomy & histology, Wasps growth & development, Wasps classification
- Abstract
Four species of Leptobatopsis Ashmead are recorded for the first time from South Korea. Among them, L. koreana sp. nov. and L. daedeokensis sp. nov. are newly described. We also report two newly recorded species, L. nigricapitis Chandra & Gupta and L. appendiculata Momoi, from South Korea. In addition, we describe a case of gynandromorphy of L. nigricapitis in a single specimen from South Korea. This specimen presents bilateral asymmetry, with the left half of its habitus displaying male characters and the right half displaying female characters. We also provide a key to Eastern Palaearctic species of Leptobatopsis.
- Published
- 2015
- Full Text
- View/download PDF
34. Medullary thyroid carcinoma with ectopic adrenocorticotropic hormone syndrome.
- Author
-
Choi HS, Kim MJ, Moon CH, Yoon JH, Ku HR, Kang GW, Na II, Lee SS, Lee BC, Park YJ, Kim HI, and Ku YH
- Abstract
Ectopic adrenocorticotropic hormone (ACTH) syndrome is caused most frequently by a bronchial carcinoid tumor or by small cell lung cancer. Medullary thyroid carcinoma (MTC) is a rare etiology of ectopic ACTH syndrome. We describe a case of Cushing syndrome due to ectopic ACTH production from MTC in a 48-year-old male. He was diagnosed with MTC 14 years ago and underwent total thyroidectomy, cervical lymph node dissection and a series of metastasectomies. MTC was confirmed by the pathological examination of the thyroid and metastatic mediastinal lymph node tissues. Two years after his last surgery, he developed Cushingoid features, such as moon face and central obesity, accompanied by uncontrolled hypertension and new-onset diabetes. The laboratory results were compatible with ectopic ACTH syndrome. A bilateral adrenalectomy improved the clinical and laboratory findings that were associated with Cushing syndrome. This is the first confirmed case of ectopic ACTH syndrome caused by MTC in Korea.
- Published
- 2014
- Full Text
- View/download PDF
35. Radioimmunotherapy with (131)i-rituximab in a patient with diffuse large B-cell lymphoma relapsed after treatment with (90)y-ibritumomab tiuxetan.
- Author
-
Kang GW, Kang HJ, Shin DY, Gu HR, Choi HS, and Lim SM
- Abstract
We report a case that demonstrates the efficacy of radioimmunotherapy (RIT) with radioiodinated rituximab ((131)I-rituximab) for relapsed diffuse large B-cell lymphoma (DLBCL). A 79-year-old male patient with DLBCL initially achieved a complete response (CR) after six cycles of R-CHOP (rituximab, cyclophosphamide, doxorubicin, vincristine and prednisone) therapy. However, the lymphoma relapsed 20 months later. Although the patient had achieved a second and a third CR after two cycles of (90)Y-ibritumomab tiuxetan, he experienced a third relapse approximately 3 years later. Between March and June 2011, the patient received three cycles of (131)I-rituximab. Although he had achieved partial response after the second cycle, the disease progressed after the third cycle, and the total progression-free survival was thus 5 months. The patient suffered only relatively mild toxicity (grade 1 thrombocytopenia) during treatment. RIT with (131)I-rituximab is therefore potentially effective in patients with relapsed DLBCL, even after the failure of (90)Y-ibritumomab tiuxetan therapy.
- Published
- 2013
- Full Text
- View/download PDF
36. Kienböck's disease associated with radiocephalic fistula formation in a patient with end-stage renal disease.
- Author
-
Kang GW, Lee DY, Lee YH, Ahn KS, Kim SK, and Lee IH
- Subjects
- Adult, Humans, Kidney Failure, Chronic pathology, Male, Osteonecrosis etiology, Osteonecrosis surgery, Radial Artery pathology, Radial Artery surgery, Risk Factors, Treatment Outcome, Vascular Patency, Arteriovenous Shunt, Surgical adverse effects, Kidney Failure, Chronic complications, Osteonecrosis diagnosis
- Abstract
Kienböck's disease, which consists of osteonecrosis and collapse of the lunate bone, causes chronic pain and dysfunction of the wrist. Patients on hemodialysis are occasionally present with wrist pain, but Kienböck's disease is rarely reported in dialysis patients. This case study describes Kienböck's disease in a patient with end-stage renal disease on hemodialysis. A 39-year-old male with a 1-year history of hemodialysis presented with left wrist pain that increased progressively over 6 months. The patient had no history of trauma or any other risk factors known to be associated with Kienböck's disease. Physical examination of the wrist at the site of the arteriovenous fistula showed swelling and tenderness with decreased range of motion. Radiographic examination showed articular collapse and fracture of the body of lunate consistent with stage IIIb Kienböck's disease. An intercarpal arthrodesis with autogenous bone graft was performed., (© 2013 The Authors. Hemodialysis International © 2013 International Society for Hemodialysis.)
- Published
- 2013
- Full Text
- View/download PDF
37. Comparison of peritoneal dialysis and hemodialysis after kidney transplant failure.
- Author
-
Kang GW, Jang MH, Hwang EA, Park SB, and Han SY
- Subjects
- Adult, Female, Humans, Male, Young Adult, Kidney Transplantation, Peritoneal Dialysis, Renal Dialysis
- Abstract
Background: Patients with a failed kidney transplant represent a unique chronic kidney disease population that is increasing in number and is at high risk of morbidity and mortality. Among transplant-naïve patients, those treated with peritoneal dialysis (PD) show an early survival advantage compared with those treated with hemodialysis (HD). But any advantage of PD after allograft failure is unknown. The aim of this study was to investigate the clinical outcomes of patients with failed allografts according to the type of dialysis modality., Method: We reviewed medical records of patients who initiated dialysis after kidney transplant failure from November 1982 to May 2011. Demographics features, clinical data, and survival outcomes were compared between PD and HD patients who had experienced allograft failure., Results: The 182 patients with failed allografts showed the most common cause to be chronic rejection. The median duration of function before allograft failure was 74.0 months. After allograft failure, 145 (79.7%) patients returned to HD and 37 (20.3%) to PD. Twenty-three patients (12.6%) died over the median 69.1 months duration of follow-up. During the observation period, 16 HD (11%) and 7 PD (8.9%) patients died. The survival rates of PD patients at 1 year were 91.2% and 84.4%, respectively, at 1 and 3 years, and those of HD patients 94.8% and 88.9%. There was no significant difference in the survivals of the 2 groups., Conclusions: The study suggests that the outcome of patients starting PD after kidney transplant failure was similar to those starting HD. Therefore, PD can be regarded to be a good treatment option for patients returning to dialysis after kidney transplant failure., (Crown Copyright © 2013. Published by Elsevier Inc. All rights reserved.)
- Published
- 2013
- Full Text
- View/download PDF
38. A case of recurrent pulmonary inflammatory myofibroblastic tumor with aggressive metastasis after complete resection.
- Author
-
Moon CH, Yoon JH, Kang GW, Lee SH, Baek JS, Kim SY, Kim HR, and Kim CH
- Abstract
An inflammatory myofibroblastic tumor (IMT) is a rare disease entity reported to arise in various organs. It is thought to be a neoplastic or reactive inflammatory condition, controversially. The treatment of choice for myofibroblastic tumor is surgery, and recurrence is known to be rare. The optimal treatment method is not well-known for patients ineligible for surgery. We report a 47-year-old patient with aggressive recurrent IMT of the lungs. The patient had been admitted for an evaluation of back-pain two years after a complete resection of pulmonary IMT. Radiation therapy was performed for multiple bone recurrences, and the symptoms were improved. However the patient presented again with aggravated back-pain six months later. High-dose steroid and non-steroidal anti-inflammatory drugs were administered, but the disease progressed aggressively, resulting in spinal cord compression and metastasis to intra-abdominal organs. This is a very rare case of aggressively recurrent pulmonary IMT with multi-organ metastasis.
- Published
- 2013
- Full Text
- View/download PDF
39. Severe lactic acidosis and acute pancreatitis associated with cimetidine in a patient with type 2 diabetes mellitus taking metformin.
- Author
-
Seo JH, Lee DY, Hong CW, Lee IH, Ahn KS, and Kang GW
- Subjects
- Acidosis, Lactic diagnosis, Aged, 80 and over, Cimetidine administration & dosage, Diabetes Mellitus, Type 2 complications, Drug Interactions physiology, Drug Therapy, Combination, Female, Humans, Hypoglycemic Agents administration & dosage, Hypoglycemic Agents adverse effects, Metformin administration & dosage, Pancreatitis diagnosis, Acidosis, Lactic chemically induced, Cimetidine adverse effects, Diabetes Mellitus, Type 2 drug therapy, Metformin adverse effects, Pancreatitis chemically induced, Severity of Illness Index
- Abstract
An 82-year-old woman with type 2 diabetes mellitus, hypertension, and unstable angina presented with severe lactic acidosis and acute kidney injury (AKI) accompanied by acute pancreatitis. Her medical history revealed that she had taken cimetidine for two weeks while taking other medications, including metformin. Continuous veno-venous hemodiafiltration (CVVHDF) was initiated under diagnosis of lactic acidosis due to metformin and AKI caused by cimetidine-induced acute pancreatitis. In three days of CVVHDF, the levels of serum biochemical markers of lactic acidosis and AKI improved and the patient's urine output reached over 1 L/day. The pancreatitis improved over time.
- Published
- 2013
- Full Text
- View/download PDF
40. Haliclonin A, a new macrocyclic diamide from the sponge Haliclona sp.
- Author
-
Jang KH, Kang GW, Jeon JE, Lim C, Lee HS, Sim CJ, Oh KB, and Shin J
- Subjects
- Animals, Anti-Bacterial Agents chemistry, Anti-Bacterial Agents pharmacology, Antineoplastic Agents chemistry, Antineoplastic Agents pharmacology, Diamines chemistry, Diamines pharmacology, Drug Screening Assays, Antitumor, Humans, K562 Cells, Macrocyclic Compounds chemistry, Macrocyclic Compounds pharmacology, Marine Biology, Molecular Structure, Nuclear Magnetic Resonance, Biomolecular, Anti-Bacterial Agents isolation & purification, Antineoplastic Agents isolation & purification, Diamines isolation & purification, Haliclona chemistry, Macrocyclic Compounds isolation & purification
- Abstract
Haliclonin A (1), a macrocyclic diamide of a novel skeletal class, was isolated from the marine sponge Haliclona sp. collected from Korean waters. The structure of this compound was determined using a combination of spectroscopic and chemical analyses. The new compound exhibited moderate cytotoxicity and antibacterial activity against diverse microbial strains.
- Published
- 2009
- Full Text
- View/download PDF
41. Nephrotoxic potential and toxicokinetics of tetrabromobisphenol A in rat for risk assessment.
- Author
-
Kang MJ, Kim JH, Shin S, Choi JH, Lee SK, Kim HS, Kim ND, Kang GW, Jeong HG, Kang W, Chun YJ, and Jeong TC
- Subjects
- Animals, Area Under Curve, Dose-Response Relationship, Drug, Flame Retardants administration & dosage, Half-Life, Male, Molecular Structure, Pharmacokinetics, Polybrominated Biphenyls administration & dosage, Polybrominated Biphenyls chemistry, Rats, Rats, Sprague-Dawley, Specific Pathogen-Free Organisms, Flame Retardants toxicity, Kidney Diseases chemically induced, Polybrominated Biphenyls toxicity
- Abstract
Tetrabromobisphenol A (TBBPA), one of the most widely used global brominated flame retardants, is used to improve fire safety of laminates in electrical and electronic equipment. To investigate the nephrotoxic potential of TBBPA and its toxicokinetic profile in rats, single-dose and daily 14-d repeated-dose toxicity studies at 200, 500, or 1000 mg/kg were performed. Several biochemical parameters were analyzed to evaluate nephrotoxicity of TBBPA. High-dose 1000 mg/kg TBBPA significantly elevated renal thiobarbituric acid-reactive substance (TBARS) levels, and superoxide dismutase (SOD) activity was increased at all 3 doses administered. This was associated with no change in the activity of catalase (CAT). Our results suggest that acute 1-d high-dose administration of TBBPA produced transient renal changes at 5 h. Subsequently, TBBPA in serum, urine, and kidney was determined by liquid chromatography-mass spectroscopy (LC/MS). Toxicokinetic studies indicated that TBBPA shows relatively a short half-life (7-9 h) and was eliminated almost completely in feces by 2 d. Based on the results from the 14-d repeated-dose study, TBBPA did not accumulate in the rat, and was eliminated in feces. The present results suggested that TBBPA may not be toxic to kidney, as the chemical is not bioavailable and is not present in renal tissue.
- Published
- 2009
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.